-
1
-
-
55749085001
-
Cachexia: A new definition
-
18718696 1:CAS:528:DC%2BD1cXhsVWrsbzI 10.1016/j.clnu.2008.06.013
-
W.J. Evans, J.E. Morley, J. Argiles, C. Bales, V. Baracos, D. Guttridge, A. Jatoi, K. Kalantar-Zadeh, H. Lochs, G. Mantovani, D. Marks, W.E. Mitch, M. Muscaritoli, A. Najand, P. Ponikowski, F. Rossi Fanelli, M. Schambelan, A. Schols, M. Schuster, D. Thomas, R. Wolfe, S.D. Anker, Cachexia: a new definition. Clin. Nutr. 27, 793-799 (2008)
-
(2008)
Clin. Nutr.
, vol.27
, pp. 793-799
-
-
Evans, W.J.1
Morley, J.E.2
Argiles, J.3
Bales, C.4
Baracos, V.5
Guttridge, D.6
Jatoi, A.7
Kalantar-Zadeh, K.8
Lochs, H.9
Mantovani, G.10
Marks, D.11
Mitch, W.E.12
Muscaritoli, M.13
Najand, A.14
Ponikowski, P.15
Rossi Fanelli, F.16
Schambelan, M.17
Schols, A.18
Schuster, M.19
Thomas, D.20
Wolfe, R.21
Anker, S.D.22
more..
-
3
-
-
0030972278
-
Wasting as independent risk factor for mortality in chronic heart failure
-
9107242 1:STN:280:DyaK2s3mtFarug%3D%3D 10.1016/S0140-6736(96)07015-8
-
S.D. Anker, P. Ponikowski, S. Varney, T.P. Chua, A.L. Clark, K.M. Webb-Peploe, D. Harrington, W.J. Kox, P. Poole-Wilson, A.J.S. Coats, Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349, 1050-1053 (1997)
-
(1997)
Lancet
, vol.349
, pp. 1050-1053
-
-
Anker, S.D.1
Ponikowski, P.2
Varney, S.3
Chua, T.P.4
Clark, A.L.5
Webb-Peploe, K.M.6
Harrington, D.7
Kox, W.J.8
Poole-Wilson, P.9
Coats, A.J.S.10
-
4
-
-
0030593939
-
Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway
-
8948566 1:CAS:528:DyaK2sXjt1OjtA%3D%3D 10.1056/NEJM199612193352507
-
W.E. Mitch, A.L. Goldberg, Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N. Engl. J. Med. 335, 1897-1905 (1996)
-
(1996)
N. Engl. J. Med.
, vol.335
, pp. 1897-1905
-
-
Mitch, W.E.1
Goldberg, A.L.2
-
5
-
-
0035164533
-
Muscle cachexia: Current concepts of intracellular mechanisms and molecular regulation
-
11141219 1:STN:280:DC%2BD3MzltlWqtQ%3D%3D 10.1097/00000658-200101000- 00003
-
P.O. Hasselgren, J.E. Fischer, Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann. Surg. 233, 9-17 (2001)
-
(2001)
Ann. Surg.
, vol.233
, pp. 9-17
-
-
Hasselgren, P.O.1
Fischer, J.E.2
-
6
-
-
35148822373
-
Effect of branched-chain amino acids on muscle atrophy in cancer cachexia
-
17623010 1:CAS:528:DC%2BD2sXhtVejt73E 10.1042/BJ20070651
-
H.L. Eley, S.T. Russell, M.J. Tisdale, Effect of branched-chain amino acids on muscle atrophy in cancer cachexia. Biochem. J. 407, 113-120 (2007)
-
(2007)
Biochem. J.
, vol.407
, pp. 113-120
-
-
Eley, H.L.1
Russell, S.T.2
Tisdale, M.J.3
-
7
-
-
79958137426
-
Skeletal muscle wasting in cachexia and sarcopenia: Molecular pathophysiology and impact of exercise training
-
21475693 10.1007/s13539-010-0007-1
-
K. Lenk, G. Schuler, V. Adams, Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J. Cachexia Sarcopenia Muscle 1, 9-21 (2010)
-
(2010)
J. Cachexia Sarcopenia Muscle
, vol.1
, pp. 9-21
-
-
Lenk, K.1
Schuler, G.2
Adams, V.3
-
8
-
-
0036342365
-
Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia
-
12163215 10.1016/S0167-5273(02)00239-5
-
M. Brink, A. Anwar, P. Delafontaine, Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia. Int. J. Cardiol. 85, 111-121 (2002)
-
(2002)
Int. J. Cardiol.
, vol.85
, pp. 111-121
-
-
Brink, M.1
Anwar, A.2
Delafontaine, P.3
-
10
-
-
0347285363
-
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
-
14718385 1:CAS:528:DC%2BD2cXmt1KgsA%3D%3D 10.1096/fj.03-0610com
-
S.H. Lecker, R.T. Jagoe, A. Gilbert, M. Gomes, V.E. Baracos, J. Bailey, S.R. Price, W.E. Mitch, A.L. Goldberg, Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18, 39-51 (2004)
-
(2004)
FASEB J.
, vol.18
, pp. 39-51
-
-
Lecker, S.H.1
Jagoe, R.T.2
Gilbert, A.3
Gomes, M.4
Baracos, V.E.5
Bailey, J.6
Price, S.R.7
Mitch, W.E.8
Goldberg, A.L.9
-
11
-
-
0029741353
-
Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats
-
1:CAS:528:DyaK28XlsV2ksbw%3D
-
M.T. Pepato, R.H. Migliorini, A.L. Goldberg, I.C. Kettelhut, Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats. Am. J. Physiol. Endocrinol. Metab. 271, E340-E347 (1996)
-
(1996)
Am. J. Physiol. Endocrinol. Metab.
, vol.271
-
-
Pepato, M.T.1
Migliorini, R.H.2
Goldberg, A.L.3
Kettelhut, I.C.4
-
12
-
-
0029001244
-
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
-
7596437 1:CAS:528:DyaK2MXmvVKjsrg%3D 10.1038/376070a0
-
T.N. Sato, Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74 (1995)
-
(1995)
Nature
, vol.376
, pp. 70-74
-
-
Sato, T.N.1
-
13
-
-
34249083804
-
Role of inflammation in the progression of heart failure
-
17470337 10.1007/BF02938356
-
A. Yndestad, J.K. Damas, E. Oie, T. Ueland, L. Gullestad, P. Aukrust, Role of inflammation in the progression of heart failure. Curr. Cardiol. Rep. 9, 236-241 (2007)
-
(2007)
Curr. Cardiol. Rep.
, vol.9
, pp. 236-241
-
-
Yndestad, A.1
Damas, J.K.2
Oie, E.3
Ueland, T.4
Gullestad, L.5
Aukrust, P.6
-
14
-
-
0032080919
-
Systemic inflammation in patients with heart failure
-
9717010 1:STN:280:DyaK1czot1Ogug%3D%3D 10.1053/euhj.1997.0858
-
D. Hasper, M. Hummel, F.X. Kleber, I. Reindl, H.D. Volk, Systemic inflammation in patients with heart failure. Eur. Heart J. 19, 761-765 (1998)
-
(1998)
Eur. Heart J.
, vol.19
, pp. 761-765
-
-
Hasper, D.1
Hummel, M.2
Kleber, F.X.3
Reindl, I.4
Volk, H.D.5
-
15
-
-
0030752660
-
Tumor necrosis factor and steroid metabolism in chronic heart failure: Possible relation to muscle wasting
-
9316530 1:STN:280:DyaK2svmt1alsg%3D%3D 10.1016/S0735-1097(97)00262-3
-
S. Anker, A.L. Clark, M. Kemp, C. Salsbury, M.M. Teixeira, P.G. Hellewell, A.J.S. Coats, Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J. Am. Coll. Cardiol. 30, 997-1001 (1997)
-
(1997)
J. Am. Coll. Cardiol.
, vol.30
, pp. 997-1001
-
-
Anker, S.1
Clark, A.L.2
Kemp, M.3
Salsbury, C.4
Teixeira, M.M.5
Hellewell, P.G.6
Coats, A.J.S.7
-
16
-
-
0033694601
-
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure
-
11104867 1:STN:280:DC%2BD3M7ktlymtA%3D%3D 10.1016/S0167-5273(00)00224-2
-
M. Rauchhaus, V. Koloczek, H. Volk, M. Kemp, J. Niebauer, D.P. Francis, A.J. Coats, S.D. Anker, Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int. J. Cardiol. 76, 125-133 (2000)
-
(2000)
Int. J. Cardiol.
, vol.76
, pp. 125-133
-
-
Rauchhaus, M.1
Koloczek, V.2
Volk, H.3
Kemp, M.4
Niebauer, J.5
Francis, D.P.6
Coats, A.J.7
Anker, S.D.8
-
17
-
-
0025286817
-
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
-
2195340 1:STN:280:DyaK3czgvF2isA%3D%3D 10.1056/NEJM199007263230405
-
B. Levine, J. Kalman, L. Mayer, H.M. Fillit, M.P. Packer, Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323, 236-241 (1990)
-
(1990)
N. Engl. J. Med.
, vol.323
, pp. 236-241
-
-
Levine, B.1
Kalman, J.2
Mayer, L.3
Fillit, H.M.4
Packer, M.P.5
-
18
-
-
0034687595
-
Plasma cytokine parameters and mortality in patients with chronic heart failure
-
11120695 1:CAS:528:DC%2BD3MXitlSltg%3D%3D 10.1161/01.CIR.102.25.3060
-
M. Rauchhaus, W. Doehner, D.P. Francis, C. Davos, M. Kemp, C. Liebenthal, J. Niebauer, J. Hooper, H.D. Volk, A.J.S. Coats, S.D. Anker, Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102, 3060-3067 (2000)
-
(2000)
Circulation
, vol.102
, pp. 3060-3067
-
-
Rauchhaus, M.1
Doehner, W.2
Francis, D.P.3
Davos, C.4
Kemp, M.5
Liebenthal, C.6
Niebauer, J.7
Hooper, J.8
Volk, H.D.9
Coats, A.J.S.10
Anker, S.D.11
-
19
-
-
0035942264
-
Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone trial (VEST)
-
11319194 1:CAS:528:DC%2BD3MXjvVarsbo%3D 10.1161/01.CIR.103.16.2055
-
A. Deswal, N.J. Petersen, A.M. Feldman, J.B. Young, B.G. White, D.L. Mann, Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103, 2055-2059 (2001)
-
(2001)
Circulation
, vol.103
, pp. 2055-2059
-
-
Deswal, A.1
Petersen, N.J.2
Feldman, A.M.3
Young, J.B.4
White, B.G.5
Mann, D.L.6
-
20
-
-
79953080703
-
Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-gamma in patients with chronic heart failure
-
21418620 1:CAS:528:DC%2BC3MXksVOqtLY%3D 10.1186/1479-5876-9-28
-
C. Cappuzzello, L. Di Vito, R. Melchionna, G. Melillo, L. Silvestri, E. Cesareo, F. Crea, G. Liuzzo, A. Facchiano, M. Capogrossi, M. Napolitano, Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-gamma in patients with chronic heart failure. J. Transl. Med. 9, 28-34 (2011)
-
(2011)
J. Transl. Med.
, vol.9
, pp. 28-34
-
-
Cappuzzello, C.1
Di Vito, L.2
Melchionna, R.3
Melillo, G.4
Silvestri, L.5
Cesareo, E.6
Crea, F.7
Liuzzo, G.8
Facchiano, A.9
Capogrossi, M.10
Napolitano, M.11
-
21
-
-
49349117049
-
Inflammatory pathways in patients with heart failure and preserved ejection fraction
-
17658631 10.1016/j.ijcard.2007.05.061
-
M. Niethammer, M. Sieber, S. von Haehling, S.D. Anker, T. Munzel, G. Horstick, S. Genth-Zotz, Inflammatory pathways in patients with heart failure and preserved ejection fraction. Int. J. Cardiol. 129, 111-117 (2008)
-
(2008)
Int. J. Cardiol.
, vol.129
, pp. 111-117
-
-
Niethammer, M.1
Sieber, M.2
Von Haehling, S.3
Anker, S.D.4
Munzel, T.5
Horstick, G.6
Genth-Zotz, S.7
-
22
-
-
0027372066
-
Acute treatment with tumor necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle
-
8264567 1:CAS:528:DyaK3sXms1yksrk%3D 10.1007/BF00926829
-
C. Garcia-Martinez, F.J. Lopez-Soriano, J.M. Argiles, Acute treatment with tumor necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol. Cell. Biochem. 125, 11-18 (1993)
-
(1993)
Mol. Cell. Biochem.
, vol.125
, pp. 11-18
-
-
Garcia-Martinez, C.1
Lopez-Soriano, F.J.2
Argiles, J.M.3
-
23
-
-
0031802331
-
Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-+B activation in response to tumor necrosis factor alpha
-
9657527 1:CAS:528:DyaK1cXktlCrsr8%3D
-
Y.P. Li, R.J. Schwartz, I.D. Waddell, B.R. Holloway, M.B. Reid, Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-B activation in response to tumor necrosis factor alpha. FASEB J. 12, 871-880 (1998)
-
(1998)
FASEB J.
, vol.12
, pp. 871-880
-
-
Li, Y.P.1
Schwartz, R.J.2
Waddell, I.D.3
Holloway, B.R.4
Reid, M.B.5
-
24
-
-
0035020568
-
IL-6-like cytokines and cancer cachexia
-
11417859 1:CAS:528:DC%2BD3MXkvFeltrc%3D 10.1385/IR:23:1:41
-
B. Barton, IL-6-like cytokines and cancer cachexia. Immunol. Res. 23, 41-58 (2001)
-
(2001)
Immunol. Res.
, vol.23
, pp. 41-58
-
-
Barton, B.1
-
25
-
-
4043154377
-
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
-
15286803 1:CAS:528:DC%2BD2cXmtlynsrY%3D
-
S. Acharyya, K.J. Ladner, L.L. Nelsen, J. Damrauer, P.J. Reiser, S. Swoap, D.C. Guttridge, Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114, 370-378 (2004)
-
(2004)
J Clin Invest
, vol.114
, pp. 370-378
-
-
Acharyya, S.1
Ladner, K.J.2
Nelsen, L.L.3
Damrauer, J.4
Reiser, P.J.5
Swoap, S.6
Guttridge, D.C.7
-
26
-
-
0026770257
-
Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice
-
1379563 1:CAS:528:DyaK38XlsV2itbo%3D 10.1101/gad.6.8.1444
-
J. Cheng, K. Turksen, Q.C. Yu, H. Schreiber, M. Teng, E. Fuchs, Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice. Genes Dev. 6, 1444-1456 (1992)
-
(1992)
Genes Dev.
, vol.6
, pp. 1444-1456
-
-
Cheng, J.1
Turksen, K.2
Yu, Q.C.3
Schreiber, H.4
Teng, M.5
Fuchs, E.6
-
27
-
-
54249107256
-
Induction of MuRF1 is essential for TNF-[alpha]-induced loss of muscle function in mice
-
18804115 1:CAS:528:DC%2BD1cXhtlSgs7bK 10.1016/j.jmb.2008.08.087
-
V. Adams, N. Mangner, A. Gasch, C. Krohne, S. Gielen, S. Hirner, H.J. Thierse, C.C. Witt, A. Linke, G. Schuler, S. Labeit, Induction of MuRF1 is essential for TNF-[alpha]-induced loss of muscle function in mice. J. Mol. Biol. 384, 48-59 (2008)
-
(2008)
J. Mol. Biol.
, vol.384
, pp. 48-59
-
-
Adams, V.1
Mangner, N.2
Gasch, A.3
Krohne, C.4
Gielen, S.5
Hirner, S.6
Thierse, H.J.7
Witt, C.C.8
Linke, A.9
Schuler, G.10
Labeit, S.11
-
28
-
-
0023638415
-
Tumors secreting human TNF/cachectin induce cachexia in mice
-
3607879 1:CAS:528:DyaL1cXmvF2kug%3D%3D 10.1016/0092-8674(87)90028-6
-
A. Oliff, D. Defeo-Jones, M. Boyer, D. Martinez, D. Kiefer, G. Vuocolo, A. Wolfe, S.H. Socher, Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50, 555-563 (1987)
-
(1987)
Cell
, vol.50
, pp. 555-563
-
-
Oliff, A.1
Defeo-Jones, D.2
Boyer, M.3
Martinez, D.4
Kiefer, D.5
Vuocolo, G.6
Wolfe, A.7
Socher, S.H.8
-
29
-
-
38949137388
-
Interleukin-6 and cachexia in ApcMin/+ mice
-
18056981 1:CAS:528:DC%2BD1cXit1yltbo%3D 10.1152/ajpregu.00716.2007
-
K.A. Baltgalvis, F.G. Berger, M.M. Pena, J.M. Davis, S.J. Muga, J.A. Carson, Interleukin-6 and cachexia in ApcMin/+ mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R393-R401 (2008)
-
(2008)
Am. J. Physiol. Regul. Integr. Comp. Physiol.
, vol.294
-
-
Baltgalvis, K.A.1
Berger, F.G.2
Pena, M.M.3
Davis, J.M.4
Muga, S.J.5
Carson, J.A.6
-
30
-
-
33747117950
-
Changes in the pro-inflammatory cytokine production and peritoneal macrophage function in rats with chronic heart failure
-
16884911 1:CAS:528:DC%2BD28XotlKjt70%3D 10.1016/j.cyto.2006.06.004
-
J. Batista, R.V.T. Santos, L.M. Cunha, K. Mattos, E.M. Oliveira, M.C.L. Seelaender, L.F.B.P. Costa Rosa, Changes in the pro-inflammatory cytokine production and peritoneal macrophage function in rats with chronic heart failure. Cytokine 34, 284-290 (2006)
-
(2006)
Cytokine
, vol.34
, pp. 284-290
-
-
Batista, J.1
Santos, R.V.T.2
Cunha, L.M.3
Mattos, K.4
Oliveira, E.M.5
Seelaender, M.C.L.6
Costa Rosa, L.7
-
31
-
-
77950202636
-
Toll-like receptor 4 mediates LPS-induced release of nitric oxide and tumor necrosis factor-alpha by embryonal cardiomyocytes: Biological significance and clinical implications in human pathology
-
20388086 1:CAS:528:DC%2BC3cXhtlCqtbnL 10.2174/138161210790883624
-
M.A. Panaro, N. Gagliardi, C. Saponaro, R. Calvello, V. Mitolo, A. Cianciulli, Toll-like receptor 4 mediates LPS-induced release of nitric oxide and tumor necrosis factor-alpha by embryonal cardiomyocytes: biological significance and clinical implications in human pathology. Curr. Pharm. Des. 16, 766-774 (2010)
-
(2010)
Curr. Pharm. Des.
, vol.16
, pp. 766-774
-
-
Panaro, M.A.1
Gagliardi, N.2
Saponaro, C.3
Calvello, R.4
Mitolo, V.5
Cianciulli, A.6
-
32
-
-
67649398797
-
Amlodipine inhibits TNF-α production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway
-
19393774 1:CAS:528:DC%2BD1MXotFyqur8%3D 10.1016/j.intimp.2009.04.010
-
X.Q. Li, W. Cao, T. Li, A.G. Zeng, L.L. Hao, X.N. Zhang, Q.B. Mei, Amlodipine inhibits TNF-α production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway. Int. Immunopharmacol. 9, 1032-1041 (2009)
-
(2009)
Int. Immunopharmacol.
, vol.9
, pp. 1032-1041
-
-
Li, X.Q.1
Cao, W.2
Li, T.3
Zeng, A.G.4
Hao, L.L.5
Zhang, X.N.6
Mei, Q.B.7
-
33
-
-
41949108771
-
Effects of IL-10 and age on IL-6, IL-1beta, and TNF-α responses in mouse skeletal and cardiac muscle to an acute inflammatory insult
-
18218915 1:CAS:528:DC%2BD1cXlsVensLw%3D 10.1152/japplphysiol.01079.2007
-
B.M. Meador, C.P. Krzyszton, R.W. Johnson, K.A. Huey, Effects of IL-10 and age on IL-6, IL-1beta, and TNF-α responses in mouse skeletal and cardiac muscle to an acute inflammatory insult. J. Appl. Physiol. 104, 991-997 (2008)
-
(2008)
J. Appl. Physiol.
, vol.104
, pp. 991-997
-
-
Meador, B.M.1
Krzyszton, C.P.2
Johnson, R.W.3
Huey, K.A.4
-
34
-
-
0142064412
-
Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1-beta, -6, and high-mobility-group protein-1 in skeletal muscle
-
12785009 1:CAS:528:DC%2BD2cXjtFWgsLg%3D 10.1097/01.shk.0000055237.25446. 80
-
C.H. Lang, C. Silvis, N. Deshpande, G. Nystrom, R.A. Frost, Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1-beta, -6, and high-mobility-group protein-1 in skeletal muscle. Shock 19, 538-546 (2003)
-
(2003)
Shock
, vol.19
, pp. 538-546
-
-
Lang, C.H.1
Silvis, C.2
Deshpande, N.3
Nystrom, G.4
Frost, R.A.5
-
35
-
-
58149106232
-
The emerging role of the gut in chronic heart failure
-
18685461 10.1097/MCO.0b013e32830a4c6e
-
A. Sandek, M. Rauchhaus, S.D. Anker, S. von Haehling, The emerging role of the gut in chronic heart failure. Curr. Opin. Clin. Nutr. Metab. Care 11, 632-639 (2008)
-
(2008)
Curr. Opin. Clin. Nutr. Metab. Care
, vol.11
, pp. 632-639
-
-
Sandek, A.1
Rauchhaus, M.2
Anker, S.D.3
Von Haehling, S.4
-
36
-
-
34948814651
-
Altered intestinal function in patients with chronic heart failure
-
17936155 1:CAS:528:DC%2BD2sXhtFKisLnF 10.1016/j.jacc.2007.07.016
-
A. Sandek, J. Bauditz, A. Swidsinski, S. Buhner, J. Weber-Eibel, S. von Haehling, W. Schroedl, T. Karhausen, W. Doehner, M. Rauchhaus, P. Poole-Wilson, H.D. Volk, H. Lochs, S.D. Anker, Altered intestinal function in patients with chronic heart failure. J. Am. Coll. Cardiol. 50, 1561-1569 (2007)
-
(2007)
J. Am. Coll. Cardiol.
, vol.50
, pp. 1561-1569
-
-
Sandek, A.1
Bauditz, J.2
Swidsinski, A.3
Buhner, S.4
Weber-Eibel, J.5
Von Haehling, S.6
Schroedl, W.7
Karhausen, T.8
Doehner, W.9
Rauchhaus, M.10
Poole-Wilson, P.11
Volk, H.D.12
Lochs, H.13
Anker, S.D.14
-
37
-
-
0036890211
-
Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure
-
12450603 1:CAS:528:DC%2BD38XovFGqtL4%3D 10.1016/S0002-9149(02)02839-4
-
S. Genth-Zotz, S. von Haehling, A.P. Bolger, P.R. Kalra, R. Wensel, A.J.S. Coats, S.D. Anker, Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. Am. J. Cardiol. 90, 1226-1230 (2002)
-
(2002)
Am. J. Cardiol.
, vol.90
, pp. 1226-1230
-
-
Genth-Zotz, S.1
Von Haehling, S.2
Bolger, A.P.3
Kalra, P.R.4
Wensel, R.5
Coats, A.J.S.6
Anker, S.D.7
-
38
-
-
0033696398
-
NF-kB mediates the protein loss induced by TNF-α in differentiated skeletal muscle
-
1:CAS:528:DC%2BD3cXns1egsbc%3D
-
Y.P. Li, M.B. Reid, NF-kB mediates the protein loss induced by TNF-α in differentiated skeletal muscle. Am. J. Physiol. 279, R1165-R1170 (2000)
-
(2000)
Am. J. Physiol.
, vol.279
-
-
Li, Y.P.1
Reid, M.B.2
-
39
-
-
32144457727
-
Intracellular signaling during skeletal muscle atrophy
-
16228971 1:CAS:528:DC%2BD28XhvVSgtL4%3D 10.1002/mus.20442
-
S.C. Kandarian, R.W. Jackman, Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 33, 155-165 (2006)
-
(2006)
Muscle Nerve
, vol.33
, pp. 155-165
-
-
Kandarian, S.C.1
Jackman, R.W.2
-
40
-
-
5444262078
-
IKK[beta]/NF-[kappa]B activation causes severe muscle wasting in mice
-
15479644 1:CAS:528:DC%2BD2cXptFahsL4%3D 10.1016/j.cell.2004.09.027
-
D. Cai, J.D. Frantz, N.E. Tawa, P.A. Melendez, B.C. Oh, H.G.W. Lidov, P.O. Hasselgren, W.R. Frontera, J. Lee, D.J. Glass, S.E. Shoelson, IKK[beta]/NF-[kappa]B activation causes severe muscle wasting in mice. Cell 119, 285-298 (2004)
-
(2004)
Cell
, vol.119
, pp. 285-298
-
-
Cai, D.1
Frantz, J.D.2
Tawa, N.E.3
Melendez, P.A.4
Oh, B.C.5
Lidov, H.G.W.6
Hasselgren, P.O.7
Frontera, W.R.8
Lee, J.9
Glass, D.J.10
Shoelson, S.E.11
-
41
-
-
0029921173
-
Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants
-
8617220 1:CAS:528:DyaK28XivVant7w%3D
-
M. Buck, M. Chojkier, Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. 15, 1753-1765 (1996)
-
(1996)
EMBO J.
, vol.15
, pp. 1753-1765
-
-
Buck, M.1
Chojkier, M.2
-
42
-
-
4544293878
-
IGF-1 stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1
-
15100091 1:CAS:528:DC%2BD2cXptVyitL0%3D 10.1152/ajpendo.00073.2004
-
J.M. Sacheck, A. Ohtsuka, S.C. McLary, A.L. Goldberg, IGF-1 stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am. J. Physiol. Endocrinol. Metab. 287, E591-E601 (2004)
-
(2004)
Am. J. Physiol. Endocrinol. Metab.
, vol.287
-
-
Sacheck, J.M.1
Ohtsuka, A.2
McLary, S.C.3
Goldberg, A.L.4
-
43
-
-
14644400387
-
TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle
-
15746179 1:CAS:528:DC%2BD2MXit1ygsbY%3D 10.1096/fj.04-2364com
-
Y.P. Li, Y. Chen, J. John, J. Moylan, B. Jin, D.L. Mann, M.B. Reid, TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J. 19, 362-370 (2005)
-
(2005)
FASEB J.
, vol.19
, pp. 362-370
-
-
Li, Y.P.1
Chen, Y.2
John, J.3
Moylan, J.4
Jin, B.5
Mann, D.L.6
Reid, M.B.7
-
44
-
-
13244298415
-
Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway
-
15550386 1:CAS:528:DC%2BD2MXmt1ynug%3D%3D 10.1074/jbc.M407517200
-
E. Latres, A.R. Amini, A.A. Amini, J. Griffiths, F.J. Martin, Y. Wei, H.C. Lin, G.D. Yancopoulos, D.J. Glass, Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J. Biol. Chem. 280, 2737-2744 (2005)
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 2737-2744
-
-
Latres, E.1
Amini, A.R.2
Amini, A.A.3
Griffiths, J.4
Martin, F.J.5
Wei, Y.6
Lin, H.C.7
Yancopoulos, G.D.8
Glass, D.J.9
-
45
-
-
33845589422
-
Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility
-
17145048 1:CAS:528:DC%2BD2sXpvVCi 10.1016/j.cardiores.2006.10.026
-
V. Adams, A. Linke, U. Wisloff, C. Doring, S. Erbs, N. Krankel, C.C. Witt, S. Labeit, U. Muller-Werdan, G. Schuler, R. Hambrecht, Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: effect on myocardial contractility. Cardiovasc. Res. 73, 120-129 (2007)
-
(2007)
Cardiovasc. Res.
, vol.73
, pp. 120-129
-
-
Adams, V.1
Linke, A.2
Wisloff, U.3
Doring, C.4
Erbs, S.5
Krankel, N.6
Witt, C.C.7
Labeit, S.8
Muller-Werdan, U.9
Schuler, G.10
Hambrecht, R.11
-
46
-
-
0036216137
-
Induction of iNOS-expression in skeletal muscle by IL-1ß and NFκB activation: An in vitro and in vivo study
-
12062366 1:CAS:528:DC%2BD38XivF2qsr4%3D 10.1016/S0008-6363(02)00228-6
-
V. Adams, B. Nehrhoff, U. Späte, A. Linke, P.C. Schulze, A. Baur, S. Gielen, R. Hambrecht, G. Schuler, Induction of iNOS-expression in skeletal muscle by IL-1ß and NFκB activation: an in vitro and in vivo study. Cardiovasc. Res. 54, 95-104 (2002)
-
(2002)
Cardiovasc. Res.
, vol.54
, pp. 95-104
-
-
Adams, V.1
Nehrhoff, B.2
Späte, U.3
Linke, A.4
Schulze, P.C.5
Baur, A.6
Gielen, S.7
Hambrecht, R.8
Schuler, G.9
-
47
-
-
22544452988
-
NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release
-
16024790 10.1128/MCB.25.15.6533-6545.2005 1:CAS:528:DC%2BD2MXntVShu74%3D
-
S. Di Marco, R. Mazroui, P. Dallaire, S. Chittur, S.A. Tenenbaum, D. Radzioch, A. Marette, I.E. Gallouzi, NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release. Mol. Cell. Biol. 25, 6533-6545 (2005)
-
(2005)
Mol. Cell. Biol.
, vol.25
, pp. 6533-6545
-
-
Di Marco, S.1
Mazroui, R.2
Dallaire, P.3
Chittur, S.4
Tenenbaum, S.A.5
Radzioch, D.6
Marette, A.7
Gallouzi, I.E.8
-
48
-
-
0037127223
-
Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor- b DNA binding activity
-
11706022 1:CAS:528:DC%2BD38XosFertg%3D%3D 10.1074/jbc.M106393200
-
B.M. Matata, M. Galinanes, Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor- B DNA binding activity. J. Biol. Chem. 277, 2330-2335 (2002)
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 2330-2335
-
-
Matata, B.M.1
Galinanes, M.2
-
49
-
-
23944448586
-
Exercise training in chronic heart failure: Correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle
-
16079649 10.1097/01.hjr.0000174824.94892.43
-
S. Gielen, V. Adams, A. Linke, S. Erbs, S. MÂbius-Winkler, A. Schubert, G. Schuler, R. Hambrecht, Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle. Eur. J. Cardiovasc. Prev. Rehabil. 12, 393-400 (2005)
-
(2005)
Eur. J. Cardiovasc. Prev. Rehabil.
, vol.12
, pp. 393-400
-
-
Gielen, S.1
Adams, V.2
Linke, A.3
Erbs, S.4
Mâbius-Winkler, S.5
Schubert, A.6
Schuler, G.7
Hambrecht, R.8
-
50
-
-
0028929328
-
Mechanisms and genes of cellular suicide
-
7878463 1:CAS:528:DyaK2MXktlClt78%3D 10.1126/science.7878463
-
H. Steller, Mechanisms and genes of cellular suicide. Science 267, 1445-1449 (1995)
-
(1995)
Science
, vol.267
, pp. 1445-1449
-
-
Steller, H.1
-
51
-
-
0034771148
-
Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-α and sphingosine
-
11603928 1:CAS:528:DC%2BD3MXnsFOjtL4%3D 10.1006/jmcc.2001.1453
-
L. Dalla-Libera, R. Sabbadini, C. Renken, B. Ravara, M. Sandri, R. Betto, A. Angelini, G. Vescovo, Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-α and sphingosine. J. Mol. Cell. Cardiol. 33, 1871-1878 (2001)
-
(2001)
J. Mol. Cell. Cardiol.
, vol.33
, pp. 1871-1878
-
-
Dalla-Libera, L.1
Sabbadini, R.2
Renken, C.3
Ravara, B.4
Sandri, M.5
Betto, R.6
Angelini, A.7
Vescovo, G.8
-
52
-
-
33746209090
-
Skeletal muscle apoptosis in experimental heart failure: The only link between inflammation and skeletal muscle wastage?
-
16778571 1:CAS:528:DC%2BD28Xot1ahsb8%3D 10.1097/01.mco.0000232902.97286. 35
-
G. Vescovo, L. Dalla-Libera, Skeletal muscle apoptosis in experimental heart failure: The only link between inflammation and skeletal muscle wastage? Curr. Opin. Clin. Nutr. Metab. Care 9, 416-422 (2006)
-
(2006)
Curr. Opin. Clin. Nutr. Metab. Care
, vol.9
, pp. 416-422
-
-
Vescovo, G.1
Dalla-Libera, L.2
-
53
-
-
0033558684
-
Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance
-
10091822 1:STN:280:DyaK1M7ptVansQ%3D%3D 10.1016/S0735-1097(98)00626-3
-
V. Adams, H. Jiang, J. Yu, S. Möbius-Winkler, E. Fiehn, A. Linke, C. Weigl, G. Schuler, R. Hambrecht, Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J. Am. Coll. Cardiol. 33, 959-965 (1999)
-
(1999)
J. Am. Coll. Cardiol.
, vol.33
, pp. 959-965
-
-
Adams, V.1
Jiang, H.2
Yu, J.3
Möbius-Winkler, S.4
Fiehn, E.5
Linke, A.6
Weigl, C.7
Schuler, G.8
Hambrecht, R.9
-
54
-
-
0037204948
-
TNF-R1 signaling: A beautiful pathway
-
12040173 1:CAS:528:DC%2BD38XktlChtrg%3D 10.1126/science.1071924
-
G. Chen, D.V. Goeddel, TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635 (2002)
-
(2002)
Science
, vol.296
, pp. 1634-1635
-
-
Chen, G.1
Goeddel, D.V.2
-
55
-
-
70349218445
-
Exercise capacity in chronic heart failure patients is related to active gene transcription in skeletal muscle and not apoptosis
-
19318954 10.1097/HJR.0b013e3283244436
-
V.M. Conraads, V.Y. Hoymans, T. Vermeulen, P. Beckers, N. Possemiers, M. De Maeseneer, C. Vrints, W. Martinet, Exercise capacity in chronic heart failure patients is related to active gene transcription in skeletal muscle and not apoptosis. Eur. J. Cardiovasc. Prev. Rehabil. 16, 325-332 (2009)
-
(2009)
Eur. J. Cardiovasc. Prev. Rehabil.
, vol.16
, pp. 325-332
-
-
Conraads, V.M.1
Hoymans, V.Y.2
Vermeulen, T.3
Beckers, P.4
Possemiers, N.5
De Maeseneer, M.6
Vrints, C.7
Martinet, W.8
-
56
-
-
15544381195
-
Future prospects of anticytokine therapy in chronic heart failure
-
10.1517/13543784.14.2.163
-
S. von Haehling, S.D. Anker, Future prospects of anticytokine therapy in chronic heart failure. Expert Opin. Investig. Drugs 14, 163-176 (2005)
-
(2005)
Expert Opin. Investig. Drugs
, vol.14
, pp. 163-176
-
-
Von Haehling, S.1
Anker, S.D.2
-
57
-
-
11144355760
-
Targeted anticytokine therapy in patients with chronic heart failure
-
15023878 1:CAS:528:DC%2BD2cXisFOqtr4%3D 10.1161/01.CIR.0000124490.27666. B2
-
D.L. Mann, J.J.V. McMurray, M. Packer, K. Swedberg, J.S. Borer, W.S. Colucci, J. Djian, H. Drexler, A. Feldman, L. Kober, H. Krum, P. Liu, M. Nieminen, L. Tavazzi, D.J. van Veldhuisen, A. Waldenstrom, M. Warren, A. Westheim, F. Zannad, T. Fleming, Targeted anticytokine therapy in patients with chronic heart failure. Circulation 109, 1594-1602 (2004)
-
(2004)
Circulation
, vol.109
, pp. 1594-1602
-
-
Mann, D.L.1
McMurray, J.J.V.2
Packer, M.3
Swedberg, K.4
Borer, J.S.5
Colucci, W.S.6
Djian, J.7
Drexler, H.8
Feldman, A.9
Kober, L.10
Krum, H.11
Liu, P.12
Nieminen, M.13
Tavazzi, L.14
Van Veldhuisen, D.J.15
Waldenstrom, A.16
Warren, M.17
Westheim, A.18
Zannad, F.19
Fleming, T.20
more..
-
58
-
-
0036888364
-
How to RECOVER from RENAISSANCE? the significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH
-
12419548 10.1016/S0167-5273(02)00470-9
-
S.D. Anker, A.J.S. Coats, How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int. J. Cardiol. 86, 123-130 (2002)
-
(2002)
Int. J. Cardiol.
, vol.86
, pp. 123-130
-
-
Anker, S.D.1
Coats, A.J.S.2
-
59
-
-
0038755661
-
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α in patients with moderate-to-severe heart failure
-
ATTACH Investigators 12796126 1:CAS:528:DC%2BD3sXkslKgtrs%3D 10.1161/01.CIR.0000077913.60364.D2
-
E.S. Chung, M. Packer, K.H. Lo, A.A. Fasanmade, J.T. Willerson, ATTACH Investigators, Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α in patients with moderate-to-severe heart failure. Circulation 107, 3133-3140 (2003)
-
(2003)
Circulation
, vol.107
, pp. 3133-3140
-
-
Chung, E.S.1
Packer, M.2
Lo, K.H.3
Fasanmade, A.A.4
Willerson, J.T.5
-
60
-
-
0026080801
-
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes
-
1997652 1:CAS:528:DyaK3MXhsFKku70%3D 10.1084/jem.173.3.699
-
E.P. Sampaio, E.N. Sarno, R. Galilly, G. Kaplan, Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J. Exp. Med. 173, 699-703 (1991)
-
(1991)
J. Exp. Med.
, vol.173
, pp. 699-703
-
-
Sampaio, E.P.1
Sarno, E.N.2
Galilly, R.3
Kaplan, G.4
-
61
-
-
0036849035
-
Effect of thalidomide in patients with chronic heart failure
-
12422154 1:CAS:528:DC%2BD38XpsVWntLY%3D
-
L. Gullestad, A.G. Semb, E. Holt, R. Skardal, T. Ueland, A. Yndestad, S.S. Froland, P. Aukrust, Effect of thalidomide in patients with chronic heart failure. Am. Heart J. 144, 847-850 (2002)
-
(2002)
Am. Heart J.
, vol.144
, pp. 847-850
-
-
Gullestad, L.1
Semb, A.G.2
Holt, E.3
Skardal, R.4
Ueland, T.5
Yndestad, A.6
Froland, S.S.7
Aukrust, P.8
-
62
-
-
20344365308
-
Agents targeting inflammation in heart failure
-
15926863 1:CAS:528:DC%2BD2MXltFyju7s%3D 10.1517/13543784.14.5.557
-
L. Gullestad, J. Kiekshus, J.K. Damas, T. Ueland, A. Yndestad, P. Aukrust, Agents targeting inflammation in heart failure. Expert Opin. Investig. Drugs 14, 557-566 (2005)
-
(2005)
Expert Opin. Investig. Drugs
, vol.14
, pp. 557-566
-
-
Gullestad, L.1
Kiekshus, J.2
Damas, J.K.3
Ueland, T.4
Yndestad, A.5
Aukrust, P.6
-
63
-
-
0036774209
-
Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure
-
12411981 1:CAS:528:DC%2BD38Xpt12rs7w%3D 10.1054/jcaf.2002.128684
-
I. Agoston, Z.I. Dibbs, F. Wang, G. Muller, J.B. Zeldis, D.L. Mann, B. Bozkurt, Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure. J. Card. Fail. 8, 306-314 (2002)
-
(2002)
J. Card. Fail.
, vol.8
, pp. 306-314
-
-
Agoston, I.1
Dibbs, Z.I.2
Wang, F.3
Muller, G.4
Zeldis, J.B.5
Mann, D.L.6
Bozkurt, B.7
-
64
-
-
33644876159
-
Effect of thalidomide on cardiac remodeling in chronic heart failure
-
16301340 1:CAS:528:DC%2BD2MXht1Cqt7zP 10.1161/CIRCULATIONAHA.105.564971
-
L. Gullestad, T. Ueland, J.G. Fjeld, E. Holt, T. Gundersen, K. Breivik, M. Folling, A. Hodt, R. Skardal, J. Kjekshus, A. Andreassen, E. Kjekshus, R. Wergeland, A. Yndestad, S.S. Froland, A.G. Semb, P. Aukrust, Effect of thalidomide on cardiac remodeling in chronic heart failure. Circulation 112, 3408-3414 (2005)
-
(2005)
Circulation
, vol.112
, pp. 3408-3414
-
-
Gullestad, L.1
Ueland, T.2
Fjeld, J.G.3
Holt, E.4
Gundersen, T.5
Breivik, K.6
Folling, M.7
Hodt, A.8
Skardal, R.9
Kjekshus, J.10
Andreassen, A.11
Kjekshus, E.12
Wergeland, R.13
Yndestad, A.14
Froland, S.S.15
Semb, A.G.16
Aukrust, P.17
-
65
-
-
85019316271
-
Effects of enalapril on morbidity and mortality in severe congestive heart failure
-
CONSENSUS Trail Study Group
-
CONSENSUS Trail Study Group, Effects of enalapril on morbidity and mortality in severe congestive heart failure. N. Engl. J. Med. 316, 1429-1431 (1987)
-
(1987)
N. Engl. J. Med.
, vol.316
, pp. 1429-1431
-
-
-
66
-
-
0025913812
-
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
-
SOLVD Investigators
-
SOLVD Investigators, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 325, 293-302 (1991)
-
(1991)
N. Engl. J. Med.
, vol.325
, pp. 293-302
-
-
-
67
-
-
0026786643
-
Effects of captopril on mortality and morbidity in patients with left ventricular dysfunktion after myocardial infarction. Result of the survival and ventricular enlargement trail
-
1386652 1:STN:280:DyaK38zlslSrtQ%3D%3D 10.1056/NEJM199209033271001
-
M.A. Pfeffer, E. Braunwald, L.A. Moye, Effects of captopril on mortality and morbidity in patients with left ventricular dysfunktion after myocardial infarction. Result of the survival and ventricular enlargement trail. N. Engl. J. Med. 327, 669-677 (1992)
-
(1992)
N. Engl. J. Med.
, vol.327
, pp. 669-677
-
-
Pfeffer, M.A.1
Braunwald, E.2
Moye, L.A.3
-
68
-
-
14844336534
-
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting
-
15650772 1:CAS:528:DC%2BD2MXhtFyjtr8%3D
-
Y.H. Song, Y. Li, J. Du, W.E. Mitch, N. Rosenthal, P. Delafontaine, Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 115, 451-458 (2005)
-
(2005)
J Clin Invest
, vol.115
, pp. 451-458
-
-
Song, Y.H.1
Li, Y.2
Du, J.3
Mitch, W.E.4
Rosenthal, N.5
Delafontaine, P.6
-
69
-
-
84856041631
-
Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy
-
22276172 1:CAS:528:DC%2BC38XitVGhurg%3D 10.1371/journal.pone.0030276
-
B.M. Rezk, T. Yoshida, L. Semprun-Prieto, Y. Higashi, S. Sukhanov, P. Delafontaine, Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy. PLoS ONE 7, e30276 (2012)
-
(2012)
PLoS ONE
, vol.7
, pp. 30276
-
-
Rezk, B.M.1
Yoshida, T.2
Semprun-Prieto, L.3
Higashi, Y.4
Sukhanov, S.5
Delafontaine, P.6
-
70
-
-
29844454514
-
Angiotensin II directly inhibits protein synthesis in murine myotubes
-
16399230 1:CAS:528:DC%2BD28XhsFGntA%3D%3D 10.1016/j.canlet.2005.02.007
-
S.T. Russell, P.M. Sanders, M.J. Tisdale, Angiotensin II directly inhibits protein synthesis in murine myotubes. Cancer Lett. 231, 290-294 (2006)
-
(2006)
Cancer Lett.
, vol.231
, pp. 290-294
-
-
Russell, S.T.1
Sanders, P.M.2
Tisdale, M.J.3
-
71
-
-
33645099219
-
Mechanism of induction of muscle protein degradation by angiotensin II
-
16257180 1:CAS:528:DC%2BD28XivVaktb0%3D 10.1016/j.cellsig.2005.09.009
-
S.T. Russell, S.M. Wyke, M.J. Tisdale, Mechanism of induction of muscle protein degradation by angiotensin II. Cell. Signal. 18, 1087-1096 (2006)
-
(2006)
Cell. Signal.
, vol.18
, pp. 1087-1096
-
-
Russell, S.T.1
Wyke, S.M.2
Tisdale, M.J.3
-
72
-
-
77951876957
-
IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression
-
20228261 1:CAS:528:DC%2BC3cXmt1Kmu7c%3D 10.1152/ajpheart.00146.2010
-
T. Yoshida, L. Semprun-Prieto, S. Sukhanov, P. Delafontaine, IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression. Am. J. Physiol. Heart Circ. Physiol. 298, H1565-H1570 (2010)
-
(2010)
Am. J. Physiol. Heart Circ. Physiol.
, vol.298
-
-
Yoshida, T.1
Semprun-Prieto, L.2
Sukhanov, S.3
Delafontaine, P.4
-
73
-
-
0037471843
-
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: An observational study
-
12672310 1:CAS:528:DC%2BD3sXisFSntL4%3D 10.1016/S0140-6736(03)12892-9
-
S.D. Anker, A. Negassa, A.J. Coats, R. Afzal, P.A. Poole-Wilson, J.N. Cohn, S. Yusuf, Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361, 1077-1083 (2003)
-
(2003)
Lancet
, vol.361
, pp. 1077-1083
-
-
Anker, S.D.1
Negassa, A.2
Coats, A.J.3
Afzal, R.4
Poole-Wilson, P.A.5
Cohn, J.N.6
Yusuf, S.7
-
74
-
-
29244445119
-
Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension
-
16274385 10.1111/j.1532-5415.2005.53568.x
-
G.D. Schellenbaum, N.L. Smith, S.R. Heckbert, T. Lumley, T.D. Rea, C.D. Furberg, M.F. Lyles, B.M. Psaty, Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension. J. Am. Geriatr. Soc. 53, 1996-2000 (2005)
-
(2005)
J. Am. Geriatr. Soc.
, vol.53
, pp. 1996-2000
-
-
Schellenbaum, G.D.1
Smith, N.L.2
Heckbert, S.R.3
Lumley, T.4
Rea, T.D.5
Furberg, C.D.6
Lyles, M.F.7
Psaty, B.M.8
-
75
-
-
2942754118
-
Antihypertensive medications and differences in muscle mass in older persons: The health, aging and body composition study
-
15161462 10.1111/j.1532-5415.2004.52265.x
-
M. Di Bari, L. Van De Poll-Franse, G. Onder, S.B. Kritchevsky, A. Newman, T.B. Harris, J.D. Williamson, N. Marchionni, M. Pahor, Antihypertensive medications and differences in muscle mass in older persons: the health, aging and body composition study. J. Am. Geriatr. Soc. 52, 961-966 (2004)
-
(2004)
J. Am. Geriatr. Soc.
, vol.52
, pp. 961-966
-
-
Di Bari, M.1
Van De Poll-Franse, L.2
Onder, G.3
Kritchevsky, S.B.4
Newman, A.5
Harris, T.B.6
Williamson, J.D.7
Marchionni, N.8
Pahor, M.9
-
76
-
-
0026076257
-
Endurance training increases metabolic rate and norepinephrine appearance rate in older individuals
-
1:CAS:528:DyaK3MXlsFWmt78%3D
-
E.T. Poehlman, E. Danforth, Endurance training increases metabolic rate and norepinephrine appearance rate in older individuals. Am. J. Physiol. Endocrinol. Metab. 261, E233-E239 (1991)
-
(1991)
Am. J. Physiol. Endocrinol. Metab.
, vol.261
-
-
Poehlman, E.T.1
Danforth, E.2
-
77
-
-
0342460492
-
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
-
9244221 1:STN:280:DyaK2szos1eksA%3D%3D 10.1161/01.CIR.96.2.526
-
S.D. Anker, T.P. Chua, P. Ponikowski, D. Harrington, J.W. Swan, W.J. Kox, P.A. Poole-Wilson, A.J.S. Coats, Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96, 526-534 (1997)
-
(1997)
Circulation
, vol.96
, pp. 526-534
-
-
Anker, S.D.1
Chua, T.P.2
Ponikowski, P.3
Harrington, D.4
Swan, J.W.5
Kox, W.J.6
Poole-Wilson, P.A.7
Coats, A.J.S.8
-
78
-
-
0029931516
-
Energy expenditure and symptom severity in men with heart failure
-
8651109 1:STN:280:DyaK283kslertw%3D%3D 10.1016/S0002-9149(96)00176-2
-
T.O. Obisesan, M.J. Toth, K. Donaldson, S.S. Gottlieb, M.L. Fisher, P. Vaitekevicius, E.T. Poehlman, Energy expenditure and symptom severity in men with heart failure. Am. J. Cardiol. 77, 1250-1252 (1996)
-
(1996)
Am. J. Cardiol.
, vol.77
, pp. 1250-1252
-
-
Obisesan, T.O.1
Toth, M.J.2
Donaldson, K.3
Gottlieb, S.S.4
Fisher, M.L.5
Vaitekevicius, P.6
Poehlman, E.T.7
-
79
-
-
0024344340
-
Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure
-
2752558 1:STN:280:DyaL1MzisVegsQ%3D%3D 10.1161/01.CIR.80.2.299
-
I.S. Anand, R. Ferrari, G.S. Kalra, P.L. Wahi, P.A. Poole-Wilson, P.C. Harris, Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 80, 299-305 (1989)
-
(1989)
Circulation
, vol.80
, pp. 299-305
-
-
Anand, I.S.1
Ferrari, R.2
Kalra, G.S.3
Wahi, P.L.4
Poole-Wilson, P.A.5
Harris, P.C.6
-
81
-
-
0031010050
-
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
-
9139826 1:CAS:528:DyaK2sXivFygur0%3D 10.1038/387083a0
-
A.C. McPherron, A.M. Lawler, S.J. Lee, Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member. Nature 387, 83-90 (1997)
-
(1997)
Nature
, vol.387
, pp. 83-90
-
-
McPherron, A.C.1
Lawler, A.M.2
Lee, S.J.3
-
82
-
-
0030840359
-
Double muscling in cattle due to mutations in the myostatin gene
-
9356471 1:CAS:528:DyaK2sXns1ylsbk%3D 10.1073/pnas.94.23.12457
-
A.C. McPherron, S.J. Lee, Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. USA 94, 12457-12461 (1997)
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 12457-12461
-
-
McPherron, A.C.1
Lee, S.J.2
-
83
-
-
2942735123
-
Myostatin mutation associated with gross muscle hypertrophy in a child
-
15215484 1:CAS:528:DC%2BD2cXltFGns7c%3D 10.1056/NEJMoa040933
-
M. Schuelke, K.R. Wagner, L.E. Stolz, C. Hubner, T. Riebel, W. Komen, T. Braun, J.F. Tobin, S.J. Lee, Myostatin mutation associated with gross muscle hypertrophy in a child. N. Engl. J. Med. 350, 2682-2688 (2004)
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 2682-2688
-
-
Schuelke, M.1
Wagner, K.R.2
Stolz, L.E.3
Hubner, C.4
Riebel, T.5
Komen, W.6
Braun, T.7
Tobin, J.F.8
Lee, S.J.9
-
84
-
-
13044265837
-
Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting
-
10.1073/pnas.95.25.14938
-
N.F. Gonzales-Cadavid, W.E. Taylor, K. Yaresheski, I. Sinha-Hikim, K. Ma, S. Ezzat, R. Shen, R. Lalani, S. Asa, M. Mamita, G. Nair, S. Arver, S. Bhasin, Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc. Natl. Acad. Sci. USA 95, 14938-14943 (1998)
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 14938-14943
-
-
Gonzales-Cadavid, N.F.1
Taylor, W.E.2
Yaresheski, K.3
Sinha-Hikim, I.4
Ma, K.5
Ezzat, S.6
Shen, R.7
Lalani, R.8
Asa, S.9
Mamita, M.10
Nair, G.11
Arver, S.12
Bhasin, S.13
-
85
-
-
0036959537
-
Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting
-
12474026 1:STN:280:DC%2BD38jhtFGlsQ%3D%3D
-
K.E. Yarasheski, S. Bhasin, I. Sinha-Hikim, J. Pak-Loduca, N.F. Gonzales-Cadavid, Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J. Nutr. Health Aging 6, 343-348 (2002)
-
(2002)
J. Nutr. Health Aging
, vol.6
, pp. 343-348
-
-
Yarasheski, K.E.1
Bhasin, S.2
Sinha-Hikim, I.3
Pak-Loduca, J.4
Gonzales-Cadavid, N.F.5
-
86
-
-
66249091925
-
Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model
-
19218333 1:CAS:528:DC%2BD1MXlvFSjtrY%3D 10.1093/eurjhf/hfp020
-
K. Lenk, R. Schur, A. Linke, S. Erbs, Y. Matsumoto, V. Adams, G. Schuler, Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model. Eur. J. Heart Fail. 11, 342-348 (2009)
-
(2009)
Eur. J. Heart Fail.
, vol.11
, pp. 342-348
-
-
Lenk, K.1
Schur, R.2
Linke, A.3
Erbs, S.4
Matsumoto, Y.5
Adams, V.6
Schuler, G.7
-
87
-
-
0037165983
-
Induction of cachexia in mice by systemically administered myostatin
-
12029139 1:CAS:528:DC%2BD38XktFanu7o%3D 10.1126/science.1069525
-
T.A. Zimmers, M.V. Davies, L.G. Koniaris, P. Haynes, A.F. Esquela, K.N. Tomkinson, A.C. McPherron, N.M. Wolfman, S.J. Lee, Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486-1488 (2002)
-
(2002)
Science
, vol.296
, pp. 1486-1488
-
-
Zimmers, T.A.1
Davies, M.V.2
Koniaris, L.G.3
Haynes, P.4
Esquela, A.F.5
Tomkinson, K.N.6
McPherron, A.C.7
Wolfman, N.M.8
Lee, S.J.9
-
88
-
-
0141864365
-
Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis
-
14517293 1:CAS:528:DC%2BD3sXotVSrurg%3D 10.1128/MCB.23.20.7230-7242.2003
-
A. Rebbapragada, H. Benchabane, J.L. Wrana, A.J. Celeste, L. Attisano, Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol. Cell. Biol. 23, 7230-7242 (2003)
-
(2003)
Mol. Cell. Biol.
, vol.23
, pp. 7230-7242
-
-
Rebbapragada, A.1
Benchabane, H.2
Wrana, J.L.3
Celeste, A.J.4
Attisano, L.5
-
89
-
-
0030891169
-
Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD
-
9094721 1:CAS:528:DyaK2sXisVyks7s%3D 10.1016/S0092-8674(00)80189-0
-
S. Tajbakhsh, D. Rocancourt, G. Cossu, M. Buckingham, Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89, 127-138 (1997)
-
(1997)
Cell
, vol.89
, pp. 127-138
-
-
Tajbakhsh, S.1
Rocancourt, D.2
Cossu, G.3
Buckingham, M.4
-
90
-
-
0030891318
-
Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue
-
9094722 1:CAS:528:DyaK2sXisVyksLc%3D 10.1016/S0092-8674(00)80190-7
-
M. Maroto, R. Reshef, A.E. Münsterberg, S. Koester, M. Goulding, A.B. Lassar, Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 89, 139-148 (1997)
-
(1997)
Cell
, vol.89
, pp. 139-148
-
-
Maroto, M.1
Reshef, R.2
Münsterberg, A.E.3
Koester, S.4
Goulding, M.5
Lassar, A.B.6
-
91
-
-
0037147210
-
Myostatin inhibits myoblast differentiation by down-regulating MyoD expression
-
12244043 1:CAS:528:DC%2BD38XpsFaktLk%3D 10.1074/jbc.M204291200
-
B. Langley, M. Thomas, A. Bishop, M. Sharma, S. Gilmour, R. Kambadur, Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem. 277, 49831-49840 (2002)
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 49831-49840
-
-
Langley, B.1
Thomas, M.2
Bishop, A.3
Sharma, M.4
Gilmour, S.5
Kambadur, R.6
-
92
-
-
36849049287
-
Myostatin signals through Pax7 to regulate satellite cell self-renewal
-
17949710 1:CAS:528:DC%2BD2sXhsVWjtLbP 10.1016/j.yexcr.2007.09.012
-
C. McFarlane, A. Hennebry, M. Thomas, E. Plummer, N. Ling, M. Sharma, R. Kambadur, Myostatin signals through Pax7 to regulate satellite cell self-renewal. Exp. Cell Res. 314, 317-329 (2008)
-
(2008)
Exp. Cell Res.
, vol.314
, pp. 317-329
-
-
McFarlane, C.1
Hennebry, A.2
Thomas, M.3
Plummer, E.4
Ling, N.5
Sharma, M.6
Kambadur, R.7
-
93
-
-
33846332013
-
Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors
-
16885393 1:CAS:528:DC%2BD2sXisFCrtbc%3D 10.1152/ajpcell.00542.2005
-
D.L. Allen, T.G. Unterman, Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am. J. Physiol. Cell Physiol. 292, C188-C199 (2007)
-
(2007)
Am. J. Physiol. Cell Physiol.
, vol.292
-
-
Allen, D.L.1
Unterman, T.G.2
-
94
-
-
2342515391
-
Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis
-
15136138 1:CAS:528:DC%2BD2cXjsl2gt70%3D 10.1016/j.ydbio.2004.01.046
-
H. Amthor, G. Nicholas, I. McKinnell, C.F. Kemp, M. Sharma, R. Kambadur, K. Patel, Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev. Biol. 270, 19-30 (2004)
-
(2004)
Dev. Biol.
, vol.270
, pp. 19-30
-
-
Amthor, H.1
Nicholas, G.2
McKinnell, I.3
Kemp, C.F.4
Sharma, M.5
Kambadur, R.6
Patel, K.7
-
95
-
-
77957353583
-
Regulation of muscle mass by follistatin and activins
-
20810712 1:CAS:528:DC%2BC3cXhtlCktbvI 10.1210/me.2010-0127
-
S.J. Lee, Y.S. Lee, T.A. Zimmers, A. Soleimani, M.M. Matzuk, K. Tsuchida, R.D. Cohn, E.R. Barton, Regulation of muscle mass by follistatin and activins. Mol. Endocrinol. 24, 1998-2008 (2010)
-
(2010)
Mol. Endocrinol.
, vol.24
, pp. 1998-2008
-
-
Lee, S.J.1
Lee, Y.S.2
Zimmers, T.A.3
Soleimani, A.4
Matzuk, M.M.5
Tsuchida, K.6
Cohn, R.D.7
Barton, E.R.8
-
96
-
-
0028918915
-
Multiple defects and perinatal death in mice deficient in follistatin
-
7885475 1:CAS:528:DyaK2MXksFKnu7c%3D 10.1038/374360a0
-
M.M. Matzuk, N. Lu, H. Vogel, K. Sellheyer, D.R. Roop, A. Bradley, Multiple defects and perinatal death in mice deficient in follistatin. Nature 374, 360-363 (1995)
-
(1995)
Nature
, vol.374
, pp. 360-363
-
-
Matzuk, M.M.1
Lu, N.2
Vogel, H.3
Sellheyer, K.4
Roop, D.R.5
Bradley, A.6
-
97
-
-
0037191752
-
Functional improvement of dystrophic muscle by myostatin blockade
-
12459784 1:CAS:528:DC%2BD38XptFCisrs%3D 10.1038/nature01154
-
S. Bogdanovich, T.O.B. Krag, E.R. Barton, L.D. Morris, L.A. Whittemore, R.S. Ahima, T.S. Khurana, Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418-421 (2002)
-
(2002)
Nature
, vol.420
, pp. 418-421
-
-
Bogdanovich, S.1
Krag, T.O.B.2
Barton, E.R.3
Morris, L.D.4
Whittemore, L.A.5
Ahima, R.S.6
Khurana, T.S.7
-
98
-
-
0037462964
-
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength
-
12559968 1:CAS:528:DC%2BD3sXmsVCmsQ%3D%3D 10.1016/S0006-291X(02)02953-4
-
L.A. Whittemore, K. Song, X. Li, J. Aghajanian, M. Davies, S. Girgenrath, J.J. Hill, M. Jalenak, P. Kelley, A. Knight, R. Maylor, D. O'Hara, A. Pearson, A. Quazi, S. Ryerson, X.Y. Tan, K.N. Tomkinson, G.M. Veldman, A. Widom, J.F. Wright, S. Wudyka, L. Zhao, N.M. Wolfman, Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem. Biophys. Res. Commun. 300, 965-971 (2003)
-
(2003)
Biochem. Biophys. Res. Commun.
, vol.300
, pp. 965-971
-
-
Whittemore, L.A.1
Song, K.2
Li, X.3
Aghajanian, J.4
Davies, M.5
Girgenrath, S.6
Hill, J.J.7
Jalenak, M.8
Kelley, P.9
Knight, A.10
Maylor, R.11
O'Hara, D.12
Pearson, A.13
Quazi, A.14
Ryerson, S.15
Tan, X.Y.16
Tomkinson, K.N.17
Veldman, G.M.18
Widom, A.19
Wright, J.F.20
Wudyka, S.21
Zhao, L.22
Wolfman, N.M.23
more..
-
99
-
-
44849140764
-
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy
-
18335515 1:CAS:528:DC%2BD1cXntFyrtrs%3D 10.1002/ana.21338
-
K.R. Wagner, J.L. Fleckenstein, A.A. Amato, R.J. Barohn, K. Bushby, D.M. Escolar, K.M. Flanigan, A. Pestronk, R. Tawil, G.I. Wolfe, M. Eagle, J.M. Florence, W.M. King, S. Pandya, V. Straub, P. Juneau, K. Meyers, C. Csimma, T. Araujo, R. Allen, S.A. Parsons, J.M. Wozney, E.R. LaVallie, J.R. Mendell, A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann. Neurol. 63, 561-571 (2008)
-
(2008)
Ann. Neurol.
, vol.63
, pp. 561-571
-
-
Wagner, K.R.1
Fleckenstein, J.L.2
Amato, A.A.3
Barohn, R.J.4
Bushby, K.5
Escolar, D.M.6
Flanigan, K.M.7
Pestronk, A.8
Tawil, R.9
Wolfe, G.I.10
Eagle, M.11
Florence, J.M.12
King, W.M.13
Pandya, S.14
Straub, V.15
Juneau, P.16
Meyers, K.17
Csimma, C.18
Araujo, T.19
Allen, R.20
Parsons, S.A.21
Wozney, J.M.22
Lavallie, E.R.23
Mendell, J.R.24
more..
-
100
-
-
77955642517
-
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival
-
20723755 1:CAS:528:DC%2BC3cXhtVKhur%2FF 10.1016/j.cell.2010.07.011
-
X. Zhou, J.L. Wang, J. Lu, Y. Song, K.S. Kwak, Q. Jiao, R. Rosenfeld, Q. Chen, T. Boone, W.S. Simonet, D.L. Lacey, A.L. Goldberg, H.Q. Han, Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531-543 (2010)
-
(2010)
Cell
, vol.142
, pp. 531-543
-
-
Zhou, X.1
Wang, J.L.2
Lu, J.3
Song, Y.4
Kwak, K.S.5
Jiao, Q.6
Rosenfeld, R.7
Chen, Q.8
Boone, T.9
Simonet, W.S.10
Lacey, D.L.11
Goldberg, A.L.12
Han, H.Q.13
-
101
-
-
79955667805
-
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
-
21282204 1:CAS:528:DC%2BC3MXlvFSmtb0%3D 10.1096/fj.10-176917
-
L. Zhang, V. Rajan, E. Lin, Z. Hu, H.Q. Han, X. Zhou, Y. Song, H. Min, X. Wang, J. Du, W.E. Mitch, Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J. 25, 1653-1663 (2011)
-
(2011)
FASEB J.
, vol.25
, pp. 1653-1663
-
-
Zhang, L.1
Rajan, V.2
Lin, E.3
Hu, Z.4
Han, H.Q.5
Zhou, X.6
Song, Y.7
Min, H.8
Wang, X.9
Du, J.10
Mitch, W.E.11
-
103
-
-
0041424822
-
Molecular mechanisms modulating muscle mass
-
12928036 1:CAS:528:DC%2BD3sXmsVCitr0%3D 10.1016/S1471-4914(03)00138-2
-
D.J. Glass, Molecular mechanisms modulating muscle mass. Trends Mol. Med. 9, 344-350 (2003)
-
(2003)
Trends Mol. Med.
, vol.9
, pp. 344-350
-
-
Glass, D.J.1
-
104
-
-
23944501319
-
Signal-transduction networks and the regulation of muscle protein degradation
-
16125109 1:CAS:528:DC%2BD2MXpsVWms7w%3D 10.1016/j.biocel.2005.02.020
-
N.J. Szewczyk, L.A. Jacobson, Signal-transduction networks and the regulation of muscle protein degradation. Int. J. Biochem. Cell Biol. 37, 1997-2011 (2005)
-
(2005)
Int. J. Biochem. Cell Biol.
, vol.37
, pp. 1997-2011
-
-
Szewczyk, N.J.1
Jacobson, L.A.2
-
105
-
-
77958604010
-
Insulin-like growth factor axis (insulin-like growth factor-I/insulin- like growth factor-binding protein-3) as a prognostic predictor of heart failure: Association with adiponectin
-
20851819 1:CAS:528:DC%2BC3cXhtlCksr7O 10.1093/eurjhf/hfq166
-
S. Watanabe, T. Tamura, K. Ono, H. Horiuchi, T. Kimura, T. Kita, Y. Furukawa, Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin. Eur. J. Heart Fail. 12, 1214-1222 (2010)
-
(2010)
Eur. J. Heart Fail.
, vol.12
, pp. 1214-1222
-
-
Watanabe, S.1
Tamura, T.2
Ono, K.3
Horiuchi, H.4
Kimura, T.5
Kita, T.6
Furukawa, Y.7
-
106
-
-
33645817709
-
Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease
-
16406300 1:CAS:528:DC%2BD28Xjs1Wqsrg%3D 10.1016/j.cca.2005.11.015
-
S.D. Lee, L.M. Chen, W.W. Kuo, W.T. Shu, W.H. Kuo, E.J. Huang, C.C. Tsai, P.C. Li, J.Y. Liu, T.H. Chen, C.Y. Huang, Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease. Clin. Chim. Acta 367, 62-68 (2006)
-
(2006)
Clin. Chim. Acta
, vol.367
, pp. 62-68
-
-
Lee, S.D.1
Chen, L.M.2
Kuo, W.W.3
Shu, W.T.4
Kuo, W.H.5
Huang, E.J.6
Tsai, C.C.7
Li, P.C.8
Liu, J.Y.9
Chen, T.H.10
Huang, C.Y.11
-
107
-
-
0035735902
-
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
-
11715022 1:CAS:528:DC%2BD3MXosVeqt7w%3D 10.1038/ncb1101-1009
-
C. Rommel, S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, T.N. Stitt, G.D. Yancopoulos, D.J. Glass, Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3, 1009-1013 (2001)
-
(2001)
Nat. Cell Biol.
, vol.3
, pp. 1009-1013
-
-
Rommel, C.1
Bodine, S.C.2
Clarke, B.A.3
Rossman, R.4
Nunez, L.5
Stitt, T.N.6
Yancopoulos, G.D.7
Glass, D.J.8
-
108
-
-
0042750799
-
Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival
-
10.4161/cc.2.3.381
-
T. Matsui, T. Nagoshi, A. Rosenzweig, Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle 2, 20-223 (2003)
-
(2003)
Cell Cycle
, vol.2
, pp. 20-223
-
-
Matsui, T.1
Nagoshi, T.2
Rosenzweig, A.3
-
109
-
-
77957769313
-
Adiponectin receptor binding proteins - Recent advances in elucidating adiponectin signalling pathways
-
C. Buechler, J. Wanninger, M. Neumeier, Adiponectin receptor binding proteins - recent advances in elucidating adiponectin signalling pathways. FEBS Lett. 584, 4280-4286 (2010)
-
(2010)
FEBS Lett.
, vol.584
, pp. 4280-4286
-
-
Buechler, C.1
Wanninger, J.2
Neumeier, M.3
-
110
-
-
11144356337
-
FOXO transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
-
15109499 1:CAS:528:DC%2BD2cXjvFemtrs%3D 10.1016/S0092-8674(04)00400-3
-
M. Sandri, C. Sandri, A. Gilbert, C. Skurk, E. Calabria, A. Picard, K. Walsh, S. Schiaffino, S.H. Lecker, A.L. Goldberg, FOXO transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399-412 (2004)
-
(2004)
Cell
, vol.117
, pp. 399-412
-
-
Sandri, M.1
Sandri, C.2
Gilbert, A.3
Skurk, C.4
Calabria, E.5
Picard, A.6
Walsh, K.7
Schiaffino, S.8
Lecker, S.H.9
Goldberg, A.L.10
-
111
-
-
33750825245
-
PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription
-
17053067 1:CAS:528:DC%2BD28Xht1WmsL3L 10.1073/pnas.0607795103
-
M. Sandri, J. Lin, C. Handschin, W. Yang, Z.P. Arany, S.H. Lecker, A.L. Goldberg, B.M. Spiegelman, PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. USA 103, 16260-16265 (2006)
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 16260-16265
-
-
Sandri, M.1
Lin, J.2
Handschin, C.3
Yang, W.4
Arany, Z.P.5
Lecker, S.H.6
Goldberg, A.L.7
Spiegelman, B.M.8
-
112
-
-
33746328957
-
Signaling pathways in skeletal muscle remodeling
-
16756483 1:CAS:528:DC%2BD28XosVKhsr8%3D 10.1146/annurev.biochem.75. 103004.142622
-
R. Bassel-Duby, E.N. Olson, Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75, 19-37 (2006)
-
(2006)
Annu. Rev. Biochem.
, vol.75
, pp. 19-37
-
-
Bassel-Duby, R.1
Olson, E.N.2
-
113
-
-
36148967254
-
Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice
-
17885675 1:CAS:528:DC%2BD2sXht12gur7M 10.1038/sj.cgt.7701091
-
C.M. Liu, Z. Yang, C.W. Liu, R. Wang, P. Tien, R. Dale, L.Q. Sun, Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice. Cancer Gene Ther. 14, 945-952 (2007)
-
(2007)
Cancer Gene Ther.
, vol.14
, pp. 945-952
-
-
Liu, C.M.1
Yang, Z.2
Liu, C.W.3
Wang, R.4
Tien, P.5
Dale, R.6
Sun, L.Q.7
-
114
-
-
0033547764
-
Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity
-
9884373 1:CAS:528:DyaK1MXnsFClug%3D%3D 10.1161/01.CIR.99.1.18
-
S. Genth-Zotz, R. Zotz, S. Geil, T. Voigtländer, J. Meyer, H. Darius, Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation 99, 18-21 (1999)
-
(1999)
Circulation
, vol.99
, pp. 18-21
-
-
Genth-Zotz, S.1
Zotz, R.2
Geil, S.3
Voigtländer, T.4
Meyer, J.5
Darius, H.6
-
115
-
-
0030010229
-
A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
-
8596546 1:CAS:528:DyaK28Xitl2ns78%3D 10.1056/NEJM199603283341301
-
S. Fazio, D. Sabatini, B. Capaldo, C. Vigorito, A. Giordano, R. Guida, F. Pardo, B. Biondi, L. Saccá, A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 334, 809-814 (1996)
-
(1996)
N. Engl. J. Med.
, vol.334
, pp. 809-814
-
-
Fazio, S.1
Sabatini, D.2
Capaldo, B.3
Vigorito, C.4
Giordano, A.5
Guida, R.6
Pardo, F.7
Biondi, B.8
Saccá, L.9
-
116
-
-
0032565361
-
Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
-
9643742 1:CAS:528:DyaK1cXjtVGlsr4%3D 10.1016/S0140-6736(97)11329-0
-
K.J. Osterziel, O. Strohm, J. Schuler, M. Friedrich, D. Hänlein, R. Willenbrock, S.D. Anker, P. Poole-Wilson, M.B. Ranke, R. Dietz, Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351, 1233-1237 (1998)
-
(1998)
Lancet
, vol.351
, pp. 1233-1237
-
-
Osterziel, K.J.1
Strohm, O.2
Schuler, J.3
Friedrich, M.4
Hänlein, D.5
Willenbrock, R.6
Anker, S.D.7
Poole-Wilson, P.8
Ranke, M.B.9
Dietz, R.10
-
117
-
-
0032213494
-
A placebo-controlled study of growth hormone in patients with congestive heart failure
-
9857924 1:CAS:528:DyaK1cXnvVCrsrs%3D 10.1053/euhj.1998.1123
-
J. Isgaard, C.H. Bergh, K. Caidahl, M. Lomsky, A. Hjalmarson, B.A. Bengtsson, A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur. Heart J. 19, 1704-1711 (1998)
-
(1998)
Eur. Heart J.
, vol.19
, pp. 1704-1711
-
-
Isgaard, J.1
Bergh, C.H.2
Caidahl, K.3
Lomsky, M.4
Hjalmarson, A.5
Bengtsson, B.A.6
-
118
-
-
0033539018
-
Increased mortality associated with growth hormone treatment in critically ill adults
-
10477776 1:CAS:528:DyaK1MXmtlGjsro%3D 10.1056/NEJM199909093411102
-
J. Takala, E. Ruokonen, N.R. Webster, M.S. Nielsen, D.F. Zandstra, G. Vundelinckx, C.J. Hinds, Increased mortality associated with growth hormone treatment in critically ill adults. N. Engl. J. Med. 341, 785-792 (1999)
-
(1999)
N. Engl. J. Med.
, vol.341
, pp. 785-792
-
-
Takala, J.1
Ruokonen, E.2
Webster, N.R.3
Nielsen, M.S.4
Zandstra, D.F.5
Vundelinckx, G.6
Hinds, C.J.7
-
119
-
-
0024561857
-
Cardiac failure responding to growth hormone
-
10.1016/S0140-6736(89)92290-3
-
R.C. Cuneo, P. Wilmshurst, C. Lowy, G. Mcgauley, P.H. Sönksen, Cardiac failure responding to growth hormone. Lancet 333, 838-839 (1989)
-
(1989)
Lancet
, vol.333
, pp. 838-839
-
-
Cuneo, R.C.1
Wilmshurst, P.2
Lowy, C.3
McGauley, G.4
Sönksen, P.H.5
-
120
-
-
0031565436
-
Treatment of end-stage cardiac failure with growth hormone
-
9107248 10.1016/S0140-6736(05)62290-8
-
J.G. ODriscoll, D.J. Green, M. Ireland, D. Kerr, R.L. Larbalestier, Treatment of end-stage cardiac failure with growth hormone. Lancet 349, 1068 (1997)
-
(1997)
Lancet
, vol.349
, pp. 1068
-
-
Odriscoll, J.G.1
Green, D.J.2
Ireland, M.3
Kerr, D.4
Larbalestier, R.L.5
-
121
-
-
0029875771
-
Androgens in men - Uses and abuses
-
8594431 1:CAS:528:DyaK28XitV2itLc%3D 10.1056/NEJM199603143341107
-
C.J. Bagatell, W.J. Bremner, Androgens in men - uses and abuses. N. Engl. J. Med. 334, 707-715 (1996)
-
(1996)
N. Engl. J. Med.
, vol.334
, pp. 707-715
-
-
Bagatell, C.J.1
Bremner, W.J.2
-
122
-
-
84875795721
-
Androgens for postmenopausal women's health
-
doi: 10.1007/s12020-012-9692-1
-
T. Montalcini, V. Migliaccio, Y. Ferro, C. Gazzaruso, A. Pujia, Androgens for postmenopausal women's health. Endocrine, (2012). doi: 10.1007/s12020-012- 9692-1
-
(2012)
Endocrine
-
-
Montalcini, T.1
Migliaccio, V.2
Ferro, Y.3
Gazzaruso, C.4
Pujia, A.5
-
123
-
-
0036170745
-
Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts male aging study
-
11836290 1:CAS:528:DC%2BD38XhsVSjurc%3D 10.1210/jc.87.2.589
-
H.A. Feldman, C. Longcope, C.A. Derby, C.B. Johannes, A.B. Araujo, A.D. Coviello, W.J. Bremner, J.B. McKinlay, Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J. Clin. Endocrinol. Metab. 87, 589-598 (2002)
-
(2002)
J. Clin. Endocrinol. Metab.
, vol.87
, pp. 589-598
-
-
Feldman, H.A.1
Longcope, C.2
Derby, C.A.3
Johannes, C.B.4
Araujo, A.B.5
Coviello, A.D.6
Bremner, W.J.7
McKinlay, J.B.8
-
124
-
-
32544432363
-
Testosterone, dehydroepiandrosterone, and physical performance in older men: Results from the Massachusetts male aging study
-
16332936 10.1210/jc.2005-1227 1:CAS:528:DC%2BD28XhsFKntL0%3D
-
A.B. O′Donnell, T.G. Travison, S.S. Harris, J.L. Tenover, J.B. McKinlay, Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts male aging study. J. Clin. Endocrinol. Metab. 91, 425-431 (2006)
-
(2006)
J. Clin. Endocrinol. Metab.
, vol.91
, pp. 425-431
-
-
Odonnell, A.B.1
Travison, T.G.2
Harris, S.S.3
Tenover, J.L.4
McKinlay, J.B.5
-
125
-
-
33750548421
-
Anabolic deficiency in men with chronic heart failure
-
17030678 1:CAS:528:DC%2BD28XhtVyitbrM 10.1161/CIRCULATIONAHA.106.649426
-
E.A. Jankowska, B. Biel, J. Majda, A. Szklarska, M. Lopuszanska, M. Medras, S.D. Anker, W. Banasiak, P.A. Poole-Wilson, P. Ponikowski, Anabolic deficiency in men with chronic heart failure. Circulation 114, 1829-1837 (2006)
-
(2006)
Circulation
, vol.114
, pp. 1829-1837
-
-
Jankowska, E.A.1
Biel, B.2
Majda, J.3
Szklarska, A.4
Lopuszanska, M.5
Medras, M.6
Anker, S.D.7
Banasiak, W.8
Poole-Wilson, P.A.9
Ponikowski, P.10
-
126
-
-
84867400324
-
Testosterone and heart failure
-
doi: 10.1007/s12020-012-9725-9
-
M. Volterrani, G. Rosano, F. Iellamo, Testosterone and heart failure. Endocrine. (2012). doi: 10.1007/s12020-012-9725-9
-
(2012)
Endocrine
-
-
Volterrani, M.1
Rosano, G.2
Iellamo, F.3
-
127
-
-
67349180243
-
Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure
-
19477405 1:CAS:528:DC%2BD1MXms1ygs78%3D 10.1016/j.cardfail.2008.12.011
-
E.A. Jankowska, G. Filippatos, B. Ponikowska, L. Borodulin-Nadzieja, S.D. Anker, W. Banasiak, P.A. Poole-Wilson, P. Ponikowski, Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J. Card. Fail. 15, 442-450 (2009)
-
(2009)
J. Card. Fail.
, vol.15
, pp. 442-450
-
-
Jankowska, E.A.1
Filippatos, G.2
Ponikowska, B.3
Borodulin-Nadzieja, L.4
Anker, S.D.5
Banasiak, W.6
Poole-Wilson, P.A.7
Ponikowski, P.8
-
128
-
-
77950551563
-
Low circulating androgens and mortality risk in heart failure
-
19875366 10.1136/hrt.2009.181065 1:CAS:528:DC%2BC3cXltl2qtrs%3D
-
G. Güder, S. Frantz, J. Bauersachs, B. Allolio, G. Ertl, C.E. Angermann, S. Störk, Low circulating androgens and mortality risk in heart failure. Heart 96, 504-509 (2010)
-
(2010)
Heart
, vol.96
, pp. 504-509
-
-
Güder, G.1
Frantz, S.2
Bauersachs, J.3
Allolio, B.4
Ertl, G.5
Angermann, C.E.6
Störk, S.7
-
129
-
-
79955396118
-
Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography
-
21339189 1:CAS:528:DC%2BC3MXltlegs7k%3D 10.1093/eurjhf/hfr007
-
E. Wehr, S. Pilz, B.O. Boehm, W. März, T. Grammer, B. Obermayer-Pietsch, Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography. Eur. J. Heart Fail. 13, 482-488 (2011)
-
(2011)
Eur. J. Heart Fail.
, vol.13
, pp. 482-488
-
-
Wehr, E.1
Pilz, S.2
Boehm, B.O.3
März, W.4
Grammer, T.5
Obermayer-Pietsch, B.6
-
130
-
-
68949172537
-
Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: A double-blind, placebo-controlled, randomized study
-
19712802 1:CAS:528:DC%2BD1MXht1SrtrrJ 10.1016/j.jacc.2009.04.078
-
G. Caminiti, M. Volterrani, F. Iellamo, G. Marazzi, R. Massaro, M. Miceli, C. Mammi, M. Piepoli, M. Fini, G.M.C. Rosano, Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: a double-blind, placebo-controlled, randomized study. J. Am. Coll. Cardiol. 54, 919-927 (2009)
-
(2009)
J. Am. Coll. Cardiol.
, vol.54
, pp. 919-927
-
-
Caminiti, G.1
Volterrani, M.2
Iellamo, F.3
Marazzi, G.4
Massaro, R.5
Miceli, M.6
Mammi, C.7
Piepoli, M.8
Fini, M.9
Rosano, G.M.C.10
-
131
-
-
84864297656
-
Testosterone supplementation in heart failure/clinical perspective
-
22511747 1:CAS:528:DC%2BC38XhtVeiu7bJ 10.1161/CIRCHEARTFAILURE.111.965632
-
M. Toma, F.A. McAlister, E.E. Coglianese, V. Vidi, S. Vasaiwala, J.A. Bakal, P.W. Armstrong, J.A. Ezekowitz, Testosterone supplementation in heart failure/clinical perspective. Circ. Heart Fail. 5, 315-321 (2012)
-
(2012)
Circ. Heart Fail.
, vol.5
, pp. 315-321
-
-
Toma, M.1
McAlister, F.A.2
Coglianese, E.E.3
Vidi, V.4
Vasaiwala, S.5
Bakal, J.A.6
Armstrong, P.W.7
Ezekowitz, J.A.8
-
132
-
-
0033983480
-
Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels
-
10683055 1:CAS:528:DC%2BD3cXht1KmtL0%3D 10.1001/jama.283.6.763
-
S. Bhasin, T.W. Storer, M. Javanbakht, N. Berman, K.E. Yarasheski, J. Phillips, M. Dike, I. Sinha-Hikim, R. Shen, R.D. Hays, G. Beall, Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 283, 763-770 (2000)
-
(2000)
JAMA
, vol.283
, pp. 763-770
-
-
Bhasin, S.1
Storer, T.W.2
Javanbakht, M.3
Berman, N.4
Yarasheski, K.E.5
Phillips, J.6
Dike, M.7
Sinha-Hikim, I.8
Shen, R.9
Hays, R.D.10
Beall, G.11
-
133
-
-
0036036456
-
Reversal of COPD-associated weight loss using the anabolic agent oxandrolone
-
12171812 1:CAS:528:DC%2BD38XntFSktLY%3D 10.1378/chest.122.2.421
-
Ss. Yeh, B. DeGuzman, T. Kramer, Reversal of COPD-associated weight loss using the anabolic agent oxandrolone. Chest 122, 421-428 (2002)
-
(2002)
Chest
, vol.122
, pp. 421-428
-
-
Yeh, S.1
Deguzman, B.2
Kramer, T.3
-
134
-
-
77953027226
-
Absence of insulin signalling in skeletal muscle is associated with reduced muscle mass and function: Evidence for decreased protein synthesis and not increased degradation
-
20431988 10.1007/s11357-009-9125-0 1:CAS:528:DC%2BC3cXlsFarurw%3D
-
E. O′Neill, J. Wilding, C. Kahn, H. Van Remmen, A. McArdle, M. Jackson, G. Close, Absence of insulin signalling in skeletal muscle is associated with reduced muscle mass and function: evidence for decreased protein synthesis and not increased degradation. AGE 32, 209-222 (2010)
-
(2010)
AGE
, vol.32
, pp. 209-222
-
-
Oneill, E.1
Wilding, J.2
Kahn, C.3
Van Remmen, H.4
McArdle, A.5
Jackson, M.6
Close, G.7
-
135
-
-
35748934782
-
Grip strength and the metabolic syndrome: Findings from the Hertfordshire Cohort Study
-
17951315 1:STN:280:DC%2BD2snksFalsQ%3D%3D 10.1093/qjmed/hcm095
-
A.A. Sayer, H.E. Syddall, E.M. Dennison, H.J. Martin, D.I.W. Phillips, C. Cooper, C.D. Byrne, Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study. QJM 100, 707-713 (2007)
-
(2007)
QJM
, vol.100
, pp. 707-713
-
-
Sayer, A.A.1
Syddall, H.E.2
Dennison, E.M.3
Martin, H.J.4
Phillips, D.I.W.5
Cooper, C.6
Byrne, C.D.7
-
136
-
-
34548459465
-
Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients
-
17438006 1:CAS:528:DC%2BD2sXhtVSgsbjJ 10.1093/ndt/gfm204
-
S.W. Lee, G.H. Park, S.W. Lee, J.H. Song, K.C. Hong, M.J. Kim, Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients. Nephrol. Dial. Transplant. 22, 2554-2562 (2007)
-
(2007)
Nephrol. Dial. Transplant.
, vol.22
, pp. 2554-2562
-
-
Lee, S.W.1
Park, G.H.2
Lee, S.W.3
Song, J.H.4
Hong, K.C.5
Kim, M.J.6
-
137
-
-
0028895981
-
Insulin sensitivity, hormonal levels and skeletal muscle protein metabolism in tumour-bearing exercising rats
-
7535077 1:CAS:528:DyaK2MXltlGjtLg%3D 10.1016/0959-8049(94)00344-5
-
P. Daneryd, L. Hafström, E. Svanberg, I. Karlberg, Insulin sensitivity, hormonal levels and skeletal muscle protein metabolism in tumour-bearing exercising rats. Eur. J. Cancer 31A, 97-103 (1995)
-
(1995)
Eur. J. Cancer
, vol.31
, pp. 97-103
-
-
Daneryd, P.1
Hafström, L.2
Svanberg, E.3
Karlberg, I.4
-
138
-
-
22244474634
-
Insulin resistance and risk of congestive heart failure
-
16030278 1:CAS:528:DC%2BD2MXmtlGks7s%3D 10.1001/jama.294.3.334
-
E. Ingelsson, J. Sundström, J. Arnlöv, B. Zethelius, L. Lind, Insulin resistance and risk of congestive heart failure. JAMA 294, 334-341 (2005)
-
(2005)
JAMA
, vol.294
, pp. 334-341
-
-
Ingelsson, E.1
Sundström, J.2
Arnlöv, J.3
Zethelius, B.4
Lind, L.5
-
139
-
-
79955765314
-
Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in postinfarct heart failure
-
21335475 1:CAS:528:DC%2BC38XitFKkur4%3D 10.1152/ajpheart.01185.2009
-
Y. Ohta, S. Kinugawa, S. Matsushima, T. Ono, M.A. Sobirin, N. Inoue, T. Yokota, K. Hirabayashi, H. Tsutsui, Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in postinfarct heart failure. Am. J. Physiol. Heart Circ. Physiol. 300, H1637-H1644 (2011)
-
(2011)
Am. J. Physiol. Heart Circ. Physiol.
, vol.300
-
-
Ohta, Y.1
Kinugawa, S.2
Matsushima, S.3
Ono, T.4
Sobirin, M.A.5
Inoue, N.6
Yokota, T.7
Hirabayashi, K.8
Tsutsui, H.9
-
140
-
-
23944480371
-
Molecular determinants of skeletal muscle mass: Getting the "aKT" together
-
16125108 1:CAS:528:DC%2BD2MXpsVWms74%3D 10.1016/j.biocel.2005.02.026
-
G.A. Nader, Molecular determinants of skeletal muscle mass: getting the "AKT" together. Int. J. Biochem. Cell Biol. 37, 1985-1996 (2005)
-
(2005)
Int. J. Biochem. Cell Biol.
, vol.37
, pp. 1985-1996
-
-
Nader, G.A.1
-
141
-
-
30844447721
-
Insulin resistance: A contributing factor to age-related muscle mass loss
-
10.1016/S1262-3636(05)73648-X
-
C. Guillet, Y. Boirie, Insulin resistance: a contributing factor to age-related muscle mass loss. Diabetes Metab. 31, 5820-5826 (2005)
-
(2005)
Diabetes Metab.
, vol.31
, pp. 5820-5826
-
-
Guillet, C.1
Boirie, Y.2
-
142
-
-
0040184557
-
Ghrelin strongly stimulates growth hormone release in humans
-
11134161 1:STN:280:DC%2BD3M7htFGhuw%3D%3D 10.1210/jc.85.12.4908
-
K. Takaya, H. Ariyasu, N. Kanamoto, H. Iwakura, A. Yoshimoto, M. Harada, K. Mori, Y. Komatsu, T. Usui, A. Shimatsu, Y. Ogawa, K. Hosoda, T. Akamizu, M. Kojima, K. Kangawa, K. Nakao, Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab. 85, 4908-4911 (2000)
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, pp. 4908-4911
-
-
Takaya, K.1
Ariyasu, H.2
Kanamoto, N.3
Iwakura, H.4
Yoshimoto, A.5
Harada, M.6
Mori, K.7
Komatsu, Y.8
Usui, T.9
Shimatsu, A.10
Ogawa, Y.11
Hosoda, K.12
Akamizu, T.13
Kojima, M.14
Kangawa, K.15
Nakao, K.16
-
143
-
-
17744374270
-
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone
-
11238504 1:CAS:528:DC%2BD3MXitFWntrk%3D 10.1210/jc.86.3.1169
-
E. Arvat, M. Maccario, L. Di Vito, F. Broglio, A. Benso, C. Gottero, M. Papotti, G. Muccioli, C. Dieguez, F.F. Casanueva, R. Deghenghi, F. Camanni, E. Ghigo, Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 86, 1169-1174 (2001)
-
(2001)
J. Clin. Endocrinol. Metab.
, vol.86
, pp. 1169-1174
-
-
Arvat, E.1
Maccario, M.2
Di Vito, L.3
Broglio, F.4
Benso, A.5
Gottero, C.6
Papotti, M.7
Muccioli, G.8
Dieguez, C.9
Casanueva, F.F.10
Deghenghi, R.11
Camanni, F.12
Ghigo, E.13
-
144
-
-
33746739498
-
Ghrelin and the short- and long-term regulation of appetite and body weight
-
16859720 1:CAS:528:DC%2BD28XotFyktL4%3D 10.1016/j.physbeh.2006.05.022
-
D.E. Cummings, Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol. Behav. 89, 71-84 (2006)
-
(2006)
Physiol. Behav.
, vol.89
, pp. 71-84
-
-
Cummings, D.E.1
-
145
-
-
79551619646
-
Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function
-
10.2174/187221411794351897
-
C. Ledderose, S. Kreth, A. Beiras-Fernandez, Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function. Recent Pat. Endocr. Metab. Immune Drug Discov. 5, 1-6 (2012)
-
(2012)
Recent Pat. Endocr. Metab. Immune Drug Discov.
, vol.5
, pp. 1-6
-
-
Ledderose, C.1
Kreth, S.2
Beiras-Fernandez, A.3
-
146
-
-
20844460120
-
Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure
-
15569841 1:CAS:528:DC%2BD2cXhtVCisbvI 10.1161/01.CIR.0000149746.62908.BB
-
N. Nagaya, J. Moriya, Y. Yasumura, M. Uematsu, F. Ono, W. Shimizu, K. Ueno, M. Kitakaze, K. Miyatake, K. Kangawa, Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110, 3674-3679 (2004)
-
(2004)
Circulation
, vol.110
, pp. 3674-3679
-
-
Nagaya, N.1
Moriya, J.2
Yasumura, Y.3
Uematsu, M.4
Ono, F.5
Shimizu, W.6
Ueno, K.7
Kitakaze, M.8
Miyatake, K.9
Kangawa, K.10
-
147
-
-
33644878162
-
Cachexia in chronic heart failure: Prognostic implications and novel therapeutic approaches
-
16332313 10.1007/BF02696650
-
Y.J. Akashi, J. Springer, S.D. Anker, Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches. Curr. Heart Fail. Rep. 2, 198-203 (2005)
-
(2005)
Curr. Heart Fail. Rep.
, vol.2
, pp. 198-203
-
-
Akashi, Y.J.1
Springer, J.2
Anker, S.D.3
-
148
-
-
81055144834
-
Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model
-
S. Palus, R. Schur, Y.J. Akashi, B. Bockmeyer, R. Datta, H. Halem, J. Dong, M.D. Culler, V. Adams, S.D. Anker, J. Springer, Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model. PLoS One, e26865 (2011)
-
(2011)
PLoS One
-
-
Palus, S.1
Schur, R.2
Akashi, Y.J.3
Bockmeyer, B.4
Datta, R.5
Halem, H.6
Dong, J.7
Culler, M.D.8
Adams, V.9
Anker, S.D.10
Springer, J.11
-
149
-
-
0028139089
-
Positional cloning of the mouse obese gene and its human homologue
-
7984236 1:CAS:528:DyaK2MXisVGqsbs%3D 10.1038/372425a0
-
Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J.M. Friedman, Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432 (1994)
-
(1994)
Nature
, vol.372
, pp. 425-432
-
-
Zhang, Y.1
Proenca, R.2
Maffei, M.3
Barone, M.4
Leopold, L.5
Friedman, J.M.6
-
150
-
-
0030847432
-
Acute stimulation of glucose metabolism in mice by leptin treatment
-
9311777 1:CAS:528:DyaK2sXmsVWqt7o%3D 10.1038/38717
-
S. Kamohara, R. Burcelin, J.L. Halaas, J.M. Friedman, M.J. Charron, Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389, 374-377 (1997)
-
(1997)
Nature
, vol.389
, pp. 374-377
-
-
Kamohara, S.1
Burcelin, R.2
Halaas, J.L.3
Friedman, J.M.4
Charron, M.J.5
-
151
-
-
0036866913
-
Leptin: A review of its peripheral actions and interactions
-
12439643 1:CAS:528:DC%2BD38XoslGlsbc%3D 10.1038/sj.ijo.0802142
-
S. Margetic, C. Gazzola, G.G. Pegg, R.A. Hill, Leptin: a review of its peripheral actions and interactions. Int. J. Obes. Relat. Metab. Disord. 26, 1407-1433 (2002)
-
(2002)
Int. J. Obes. Relat. Metab. Disord.
, vol.26
, pp. 1407-1433
-
-
Margetic, S.1
Gazzola, C.2
Pegg, G.G.3
Hill, R.A.4
-
152
-
-
56249110497
-
Brain regulation of appetite and satiety
-
19026933 1:CAS:528:DC%2BD1MXhsV2hu7k%3D 10.1016/j.ecl.2008.08.005
-
R.S. Ahima, D.A. Antwi, Brain regulation of appetite and satiety. Endocrinol. Metab. Clin. North Am. 37, 811-823 (2008)
-
(2008)
Endocrinol. Metab. Clin. North Am.
, vol.37
, pp. 811-823
-
-
Ahima, R.S.1
Antwi, D.A.2
-
153
-
-
0032189670
-
Hyperleptinaemia in chronic heart failure
-
9820994 1:STN:280:DyaK1M%2FjvVCgtw%3D%3D 10.1053/euhj.1998.1045
-
F. Leyva, S.D. Anker, K. Egerer, J.C. Stevenson, W.J. Kox, A.J.S. Coats, Hyperleptinaemia in chronic heart failure. Eur. Heart J. 19, 1547-1551 (1998)
-
(1998)
Eur. Heart J.
, vol.19
, pp. 1547-1551
-
-
Leyva, F.1
Anker, S.D.2
Egerer, K.3
Stevenson, J.C.4
Kox, W.J.5
Coats, A.J.S.6
-
154
-
-
0033709707
-
Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system
-
11104865 1:STN:280:DC%2BD3M7ktlymtg%3D%3D 10.1016/S0167-5273(00)00397-1
-
G.S. Filippatos, K. Tsilias, K. Venetsanou, E. Karambinos, D. Manolatos, A. Kranidis, J. Antonellis, F. Kardaras, L. Anthopoulos, G. Baltopoulos, Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system. Int. J. Cardiol. 76, 117-122 (2000)
-
(2000)
Int. J. Cardiol.
, vol.76
, pp. 117-122
-
-
Filippatos, G.S.1
Tsilias, K.2
Venetsanou, K.3
Karambinos, E.4
Manolatos, D.5
Kranidis, A.6
Antonellis, J.7
Kardaras, F.8
Anthopoulos, L.9
Baltopoulos, G.10
-
155
-
-
0035210722
-
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia
-
11720897 1:CAS:528:DC%2BD3MXpt1Ght7k%3D 10.1530/eje.0.1450727
-
W. Doehner, C.D. Pflaum, M. Rauchhaus, I.F. Godsland, K. Egerer, M. Cicoira, V.G. Florea, R. Sharma, A.P. Bolger, A.J. Coats, S.D. Anker, C.J. Strasburger, Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. Eur. J. Endocrinol. 145, 727-735 (2001)
-
(2001)
Eur. J. Endocrinol.
, vol.145
, pp. 727-735
-
-
Doehner, W.1
Pflaum, C.D.2
Rauchhaus, M.3
Godsland, I.F.4
Egerer, K.5
Cicoira, M.6
Florea, V.G.7
Sharma, R.8
Bolger, A.P.9
Coats, A.J.10
Anker, S.D.11
Strasburger, C.J.12
-
156
-
-
27744536240
-
Leptin as a new diagnostic tool in chronic heart failure
-
16005450 1:CAS:528:DC%2BD2MXht1Sqs7zF 10.1016/j.cccn.2005.05.019
-
P.C. Schulze, J. Kratzsch, Leptin as a new diagnostic tool in chronic heart failure. Clin. Chim. Acta 362, 1-11 (2005)
-
(2005)
Clin. Chim. Acta
, vol.362
, pp. 1-11
-
-
Schulze, P.C.1
Kratzsch, J.2
-
157
-
-
12244309089
-
Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure
-
12559213 10.1016/S1388-9842(02)00177-0
-
P.C. Schulze, J. Kratzsch, A. Linke, N. Schoene, V. Adams, S. Gielen, S. Erbs, S. Moebius-Winkler, G. Schuler, Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur. J. Heart Fail. 5, 33-40 (2003)
-
(2003)
Eur. J. Heart Fail.
, vol.5
, pp. 33-40
-
-
Schulze, P.C.1
Kratzsch, J.2
Linke, A.3
Schoene, N.4
Adams, V.5
Gielen, S.6
Erbs, S.7
Moebius-Winkler, S.8
Schuler, G.9
-
158
-
-
0033775092
-
Leptin attenuates cardiac contraction in rat ventricular myocytes: Role of NO
-
11040226 1:CAS:528:DC%2BD3cXnslChu70%3D 10.1161/01.HYP.36.4.501
-
M.W. Nickola, L.E. Wold, P.B. Colligan, G.J. Wang, W.K. Samson, J. Ren, Leptin attenuates cardiac contraction in rat ventricular myocytes: role of NO. Hypertension 36, 501-505 (2000)
-
(2000)
Hypertension
, vol.36
, pp. 501-505
-
-
Nickola, M.W.1
Wold, L.E.2
Colligan, P.B.3
Wang, G.J.4
Samson, W.K.5
Ren, J.6
-
159
-
-
77953670617
-
Leptin signaling in the failing and mechanically unloaded human heart/CLINICAL PERSPECTIVE
-
19919993 1:CAS:528:DC%2BD1MXhtlyqsLbJ 10.1161/CIRCHEARTFAILURE.109.869909
-
K.R. McGaffin, C.S. Moravec, C.F. McTiernan, Leptin signaling in the failing and mechanically unloaded human heart/CLINICAL PERSPECTIVE. Circ. Heart Fail. 2, 676-683 (2009)
-
(2009)
Circ. Heart Fail.
, vol.2
, pp. 676-683
-
-
McGaffin, K.R.1
Moravec, C.S.2
McTiernan, C.F.3
-
160
-
-
1542316258
-
Leptin deficiency produces contrasting phenotypes in bones of the limb and spine
-
15003785 1:CAS:528:DC%2BD2cXhvFaltbc%3D 10.1016/j.bone.2003.11.020
-
M.W. Hamrick, C. Pennington, D. Newton, D. Xie, C. Isales, Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34, 376-383 (2004)
-
(2004)
Bone
, vol.34
, pp. 376-383
-
-
Hamrick, M.W.1
Pennington, C.2
Newton, D.3
Xie, D.4
Isales, C.5
-
161
-
-
0033860107
-
Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse
-
10951544 1:CAS:528:DC%2BD3cXmsVWhsbw%3D 10.1038/sj.ijo.0801357
-
S.A. Warmington, R. Tolan, S. McBennett, Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse. Int. J. Obes. Relat. Metab. Disord. 24, 1040-1050 (2000)
-
(2000)
Int. J. Obes. Relat. Metab. Disord.
, vol.24
, pp. 1040-1050
-
-
Warmington, S.A.1
Tolan, R.2
McBennett, S.3
-
162
-
-
77956907521
-
The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice
-
20800581 1:CAS:528:DC%2BC3cXht1WltrjE 10.1016/j.bbrc.2010.08.079
-
M.W. Hamrick, S. Herberg, P. Arounleut, H.Z. He, A. Shiver, R.Q. Qi, L. Zhou, C.M. Isales, Q.S. Mi, The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem. Biophys. Res. Commun. 400, 379-383 (2010)
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.400
, pp. 379-383
-
-
Hamrick, M.W.1
Herberg, S.2
Arounleut, P.3
He, H.Z.4
Shiver, A.5
Qi, R.Q.6
Zhou, L.7
Isales, C.M.8
Mi, Q.S.9
-
163
-
-
79960811213
-
Leptin gene transfer regulates fibromuscular development and lipid deposition in muscles via SIRT1, FOXO3a and PGC-1α in mice in vivo
-
21617847 1:CAS:528:DC%2BC3MXht1Cru7zF
-
Y.Z. Wang, Y.N. Huang, K.Y. Sun, J.H. Qi, L. Xiang, Leptin gene transfer regulates fibromuscular development and lipid deposition in muscles via SIRT1, FOXO3a and PGC-1α in mice in vivo. Int. J. Mol. Med. 28, 617-623 (2011)
-
(2011)
Int. J. Mol. Med.
, vol.28
, pp. 617-623
-
-
Wang, Y.Z.1
Huang, Y.N.2
Sun, K.Y.3
Qi, J.H.4
Xiang, L.5
-
164
-
-
0030991606
-
Analysis of an expression profile of genes in the human adipose tissue
-
9197538 1:CAS:528:DyaK2sXitl2ktL8%3D 10.1016/S0378-1119(96)00730-5
-
K. Maeda, K. Okubo, I. Shimomura, K. Mizuno, Y. Matsuzawa, K. Matsubara, Analysis of an expression profile of genes in the human adipose tissue. Gene 190, 227-235 (1997)
-
(1997)
Gene
, vol.190
, pp. 227-235
-
-
Maeda, K.1
Okubo, K.2
Shimomura, I.3
Mizuno, K.4
Matsuzawa, Y.5
Matsubara, K.6
-
165
-
-
0037180472
-
Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice
-
12451000 1:CAS:528:DC%2BD38XoslSnsbw%3D 10.1161/01.CIR.0000042707.50032. 19
-
Y. Okamoto, S. Kihara, N. Ouchi, M. Nishida, Y. Arita, M. Kumada, K. Ohashi, N. Sakai, I. Shimomura, H. Kobayashi, N. Terasaka, T. Inaba, T. Funahashi, Y. Matsuzawa, Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106, 2767-2770 (2002)
-
(2002)
Circulation
, vol.106
, pp. 2767-2770
-
-
Okamoto, Y.1
Kihara, S.2
Ouchi, N.3
Nishida, M.4
Arita, Y.5
Kumada, M.6
Ohashi, K.7
Sakai, N.8
Shimomura, I.9
Kobayashi, H.10
Terasaka, N.11
Inaba, T.12
Funahashi, T.13
Matsuzawa, Y.14
-
166
-
-
33644683065
-
Adiponectin inhibits endothelial synthesis of interleukin-8
-
16269654 1:CAS:528:DC%2BD2MXht1yjurfK 10.1161/01.RES.0000194328.57164.36
-
C. Kobashi, M. Urakaze, M. Kishida, E. Kibayashi, H. Kobayashi, S. Kihara, T. Funahashi, M. Takata, R. Temaru, A. Sato, K. Yamazaki, N. Nakamura, M. Kobayashi, Adiponectin inhibits endothelial synthesis of interleukin-8. Circ. Res. 97, 1245-1252 (2005)
-
(2005)
Circ. Res.
, vol.97
, pp. 1245-1252
-
-
Kobashi, C.1
Urakaze, M.2
Kishida, M.3
Kibayashi, E.4
Kobayashi, H.5
Kihara, S.6
Funahashi, T.7
Takata, M.8
Temaru, R.9
Sato, A.10
Yamazaki, K.11
Nakamura, N.12
Kobayashi, M.13
-
167
-
-
33748933358
-
Serum concentrations of adiponectin and risk of type 2 Diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: Results from the 18-Year follow-up of a large cohort from southern Germany
-
17010797 1:CAS:528:DC%2BD28XhtVagtLfL 10.1016/j.jacc.2006.06.053
-
W. Koenig, N. Khuseyinova, J. Baumert, C. Meisinger, H. Löwel, Serum concentrations of adiponectin and risk of type 2 Diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-Year follow-up of a large cohort from southern Germany. J. Am. Coll. Cardiol. 48, 1369-1377 (2006)
-
(2006)
J. Am. Coll. Cardiol.
, vol.48
, pp. 1369-1377
-
-
Koenig, W.1
Khuseyinova, N.2
Baumert, J.3
Meisinger, C.4
Löwel, H.5
-
168
-
-
0042466384
-
Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans
-
12736161 1:CAS:528:DC%2BD3sXnsVGmt7g%3D
-
J.M. Bruun, A.S. Lihn, C. Verdich, S.B. Pedersen, S. Toubro, A. Astrup, B. Richelsen, Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am. J. Physiol. Endocrinol. Metab. 285, E527-E533 (2003)
-
(2003)
Am. J. Physiol. Endocrinol. Metab.
, vol.285
-
-
Bruun, J.M.1
Lihn, A.S.2
Verdich, C.3
Pedersen, S.B.4
Toubro, S.5
Astrup, A.6
Richelsen, B.7
-
169
-
-
84863455519
-
Adipokines and systemic inflammation in weight-losing lung cancer patients
-
22246553 1:CAS:528:DC%2BC38XmsVegtLs%3D 10.1007/s00408-011-9364-6
-
S.T. Gulen, F. Karadag, A.B. Karul, N. Kilicarslan, E. Ceylan, N.K. Kuman, O. Cildag, Adipokines and systemic inflammation in weight-losing lung cancer patients. Lung 190, 327-332 (2012)
-
(2012)
Lung
, vol.190
, pp. 327-332
-
-
Gulen, S.T.1
Karadag, F.2
Karul, A.B.3
Kilicarslan, N.4
Ceylan, E.5
Kuman, N.K.6
Cildag, O.7
-
170
-
-
25444506344
-
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
-
16157772 1:CAS:528:DC%2BD2MXpvFGqsLw%3D 10.1161/CIRCULATIONAHA.104.530972
-
C. Kistorp, J. Faber, S. Galatius, F. Gustafsson, J. Frystyk, A. Flyvbjerg, P. Hildebrandt, Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112, 1756-1762 (2005)
-
(2005)
Circulation
, vol.112
, pp. 1756-1762
-
-
Kistorp, C.1
Faber, J.2
Galatius, S.3
Gustafsson, F.4
Frystyk, J.5
Flyvbjerg, A.6
Hildebrandt, P.7
-
171
-
-
33750080744
-
Circulating adiponectin concentrations in patients with congestive heart failure
-
16621874 1:CAS:528:DC%2BD28Xht1Shur3K 10.1136/hrt.2005.083345
-
J. George, S. Patal, D. Wexler, Y. Sharabi, E. Peleg, Y. Kamari, E. Grossman, D. Sheps, G. Keren, A. Roth, Circulating adiponectin concentrations in patients with congestive heart failure. Heart 92, 1420-1424 (2006)
-
(2006)
Heart
, vol.92
, pp. 1420-1424
-
-
George, J.1
Patal, S.2
Wexler, D.3
Sharabi, Y.4
Peleg, E.5
Kamari, Y.6
Grossman, E.7
Sheps, D.8
Keren, G.9
Roth, A.10
-
172
-
-
34247614098
-
Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure
-
17456982 1:CAS:528:DC%2BD2sXlvVSmtbk%3D 10.1253/circj.71.623
-
T. Tamura, Y. Furukawa, R. Taniguchi, Y. Sato, K. Ono, H. Horiuchi, Y. Nakagawa, T. Kita, T. Kimura, Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ. J. 71, 623-630 (2007)
-
(2007)
Circ. J.
, vol.71
, pp. 623-630
-
-
Tamura, T.1
Furukawa, Y.2
Taniguchi, R.3
Sato, Y.4
Ono, K.5
Horiuchi, H.6
Nakagawa, Y.7
Kita, T.8
Kimura, T.9
-
173
-
-
34548355070
-
Increase in serum adiponectin concentration in patients with heart failure and cachexia: Relationship with leptin, other cytokines, and B-type natriuretic peptide
-
17403719 1:CAS:528:DC%2BD2sXmtFeksb8%3D 10.1093/eurheartj/ehm033
-
M.B. McEntegart, B. Awede, M.C. Petrie, N. Sattar, F.G. Dunn, N.G. MacFarlane, J.J.V. McMurray, Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur. Heart J. 28, 829-835 (2007)
-
(2007)
Eur. Heart J.
, vol.28
, pp. 829-835
-
-
McEntegart, M.B.1
Awede, B.2
Petrie, M.C.3
Sattar, N.4
Dunn, F.G.5
Macfarlane, N.G.6
McMurray, J.J.V.7
-
174
-
-
0035852760
-
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
-
11172066 1:CAS:528:DC%2BD3MXhsVWit78%3D 10.1073/pnas.98.4.2005
-
J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson, F.T. Yen, B.E. Bihain, H.F. Lodish, Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA 98, 2005-2010 (2001)
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 2005-2010
-
-
Fruebis, J.1
Tsao, T.S.2
Javorschi, S.3
Ebbets-Reed, D.4
Erickson, M.R.5
Yen, F.T.6
Bihain, B.E.7
Lodish, H.F.8
-
175
-
-
2442659256
-
Adiponectin acts in the brain to decease body weight
-
15077108 1:CAS:528:DC%2BD2cXjsF2jtLw%3D 10.1038/nm1029
-
Y. Qi, N. Takahashi, S.M. Hileman, H.R. Patel, A.H. Berg, U.B. Pajvani, P.E. Scherer, R.S. Ahima, Adiponectin acts in the brain to decease body weight. Nat. Med. 10, 524-529 (2004)
-
(2004)
Nat. Med.
, vol.10
, pp. 524-529
-
-
Qi, Y.1
Takahashi, N.2
Hileman, S.M.3
Patel, H.R.4
Berg, A.H.5
Pajvani, U.B.6
Scherer, P.E.7
Ahima, R.S.8
-
176
-
-
70549085889
-
Exercise training reduces circulating adiponectin levels in patients with chronic heart failure
-
19656085 10.1042/CS20090213 1:CAS:528:DC%2BD1MXhsVajtL7F
-
An.M. Van Berendoncks, P. Beckers, V.Y. Hoymans, N. Possemiers, F.L. Wuyts, C.J. Vrints, V.M. Conraads, Exercise training reduces circulating adiponectin levels in patients with chronic heart failure. Clin. Sci. 118, 281-289 (2010)
-
(2010)
Clin. Sci.
, vol.118
, pp. 281-289
-
-
Van Berendoncks, A.1
Beckers, P.2
Hoymans, V.Y.3
Possemiers, N.4
Wuyts, F.L.5
Vrints, C.J.6
Conraads, V.M.7
-
177
-
-
0034937088
-
Physical training reduces peripheral markers of inflammation in patients with chronic heart failure
-
11350112 1:STN:280:DC%2BD3M3lt1Cnuw%3D%3D 10.1053/euhj.2000.2285
-
S. Adamopoulos, J. Parissis, C. Kroupis, M. Georgiadis, D. Karatzas, G. Karavolias, K. Koniavitou, A.J.S. Coats, D.Th. Kremastinos, Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur. Heart J. 22, 791-797 (2001)
-
(2001)
Eur. Heart J.
, vol.22
, pp. 791-797
-
-
Adamopoulos, S.1
Parissis, J.2
Kroupis, C.3
Georgiadis, M.4
Karatzas, D.5
Karavolias, G.6
Koniavitou, K.7
Coats, A.J.S.8
Kremastinos, D.9
-
178
-
-
79959431694
-
Effect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failure
-
21403878
-
N.A. Smart, A.I. Larsen, J.P. Le Maitre, A.S. Ferraz, Effect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failure. Cardiol. Res. Pract. 2011, 532620 (2011)
-
(2011)
Cardiol. Res. Pract.
, vol.2011
, pp. 532620
-
-
Smart, N.A.1
Larsen, A.I.2
Le Maitre, J.P.3
Ferraz, A.S.4
-
179
-
-
20244363895
-
Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure
-
12957433 1:CAS:528:DC%2BD3sXnsleitbY%3D 10.1016/S0735-1097(03)00848-9
-
S. Gielen, V. Adams, S. Möbius-Winkler, A. Linke, S. Erbs, J. Yu, W. Kempf, A. Schubert, G. Schuler, R. Hambrecht, Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J. Am. Coll. Cardiol. 42, 861-868 (2003)
-
(2003)
J. Am. Coll. Cardiol.
, vol.42
, pp. 861-868
-
-
Gielen, S.1
Adams, V.2
Möbius-Winkler, S.3
Linke, A.4
Erbs, S.5
Yu, J.6
Kempf, W.7
Schubert, A.8
Schuler, G.9
Hambrecht, R.10
-
180
-
-
71649090304
-
Exercise training changes IL-10/TNF-[alpha] ratio in the skeletal muscle of post-MI rats
-
19948415 1:CAS:528:DC%2BD1MXhsFyku7jE 10.1016/j.cyto.2009.10.007
-
J. Batista, J.C. Rosa, R.D. Lopes, F.S. Lira, J. Martins, A.S. Yamashita, P.C. Brum, J. Lancha, A.C. Lopes, M. Seelaender, Exercise training changes IL-10/TNF-[alpha] ratio in the skeletal muscle of post-MI rats. Cytokine 49, 102-108 (2010)
-
(2010)
Cytokine
, vol.49
, pp. 102-108
-
-
Batista, J.1
Rosa, J.C.2
Lopes, R.D.3
Lira, F.S.4
Martins, J.5
Yamashita, A.S.6
Brum, P.C.7
Lancha, J.8
Lopes, A.C.9
Seelaender, M.10
-
181
-
-
20244361944
-
Antioxidative effects of exercise training in patients with chronic heart failure. Increase in radical scavenger enzyme activity in skeletal muscle
-
15809365 1:CAS:528:DC%2BD2MXivFelurw%3D 10.1161/01.CIR.0000165503.08661. E5
-
A. Linke, V. Adams, P.C. Schulze, S. Erbs, S. Gielen, E. Fiehn, S. Möbius-Winkler, A. Schubert, G. Schuler, R. Hambrecht, Antioxidative effects of exercise training in patients with chronic heart failure. Increase in radical scavenger enzyme activity in skeletal muscle. Circulation 111, 1763-1770 (2005)
-
(2005)
Circulation
, vol.111
, pp. 1763-1770
-
-
Linke, A.1
Adams, V.2
Schulze, P.C.3
Erbs, S.4
Gielen, S.5
Fiehn, E.6
Möbius-Winkler, S.7
Schubert, A.8
Schuler, G.9
Hambrecht, R.10
-
182
-
-
84861881181
-
Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: The randomized leipzig exercise intervention in chronic heart failure and aging (LEICA) catabolism study
-
S. Gielen, M. Sandri, I. Kozarez, J. Kratsch, D. Teupser, J. Thiery, S. Erbs, N. Mangner, K. Lenk, R. Hambrecht, G. Schuler, V. Adams, Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized leipzig exercise intervention in chronic heart failure and aging (LEICA) catabolism study. Circulation 125, 2716-2727 (2012)
-
(2012)
Circulation
, vol.125
, pp. 2716-2727
-
-
Gielen, S.1
Sandri, M.2
Kozarez, I.3
Kratsch, J.4
Teupser, D.5
Thiery, J.6
Erbs, S.7
Mangner, N.8
Lenk, K.9
Hambrecht, R.10
Schuler, G.11
Adams, V.12
-
183
-
-
84871788794
-
Anabolic effects of exercise training in patients with advanced chronic heart failure (NYHA IIIb): Impact on ubiquitin-protein ligases expression and skeletal muscle size
-
R. Höllriegel, E.B. Beck, A. Linke, V. Adams, S. Möbius-Winkler, N. Mangner, M. Sandri, S. Gielen, M. Gutberlet, R. Hambrecht, G. Schuler, S. Erbs, Anabolic effects of exercise training in patients with advanced chronic heart failure (NYHA IIIb): impact on ubiquitin-protein ligases expression and skeletal muscle size. Int. J. Cardiol., (2012)
-
(2012)
Int. J. Cardiol.
-
-
Höllriegel, R.1
Beck, E.B.2
Linke, A.3
-
184
-
-
34548463369
-
Blood flow restriction during low-intensity resistance exercise increases S6K1 phosphorylation and muscle protein synthesis
-
17569770 1:CAS:528:DC%2BD2sXhtFalsbvM 10.1152/japplphysiol.00195.2007
-
S. Fujita, T. Abe, M.J. Drummond, J.G. Cadenas, H.C. Dreyer, Y. Sato, E. Volpi, B.B. Rasmussen, Blood flow restriction during low-intensity resistance exercise increases S6K1 phosphorylation and muscle protein synthesis. J. Appl. Physiol. 103, 903-910 (2007)
-
(2007)
J. Appl. Physiol.
, vol.103
, pp. 903-910
-
-
Fujita, S.1
Abe, T.2
Drummond, M.J.3
Cadenas, J.G.4
Dreyer, H.C.5
Sato, Y.6
Volpi, E.7
Rasmussen, B.B.8
-
185
-
-
0032948278
-
Phosphorylation of p70S6k correlates with increased skeletal muscle mass following resistance exercise
-
1:CAS:528:DyaK1MXnt12qtw%3D%3D
-
K. Baar, K. Esser, Phosphorylation of p70S6k correlates with increased skeletal muscle mass following resistance exercise. Am. J. Physiol. Cell Physiol. 276, C120-C127 (1999)
-
(1999)
Am. J. Physiol. Cell Physiol.
, vol.276
-
-
Baar, K.1
Esser, K.2
-
186
-
-
23944447604
-
Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure
-
16079650 10.1097/01.hjr.0000173106.68485.b7
-
R. Hambrecht, P.C. Schulze, S. Gielen, A. Linke, S. Möbius-Winkler, S. Erbs, J. Kratzsch, A. Schubert, V. Adams, G. Schuler, Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur. J. Cardiovasc. Prev. Rehabil. 12, 401-416 (2005)
-
(2005)
Eur. J. Cardiovasc. Prev. Rehabil.
, vol.12
, pp. 401-416
-
-
Hambrecht, R.1
Schulze, P.C.2
Gielen, S.3
Linke, A.4
Möbius-Winkler, S.5
Erbs, S.6
Kratzsch, J.7
Schubert, A.8
Adams, V.9
Schuler, G.10
|